<?xml version="1.0" encoding="UTF-8"?>
<TEI xml:space="preserve" xmlns="http://www.tei-c.org/ns/1.0" 
xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" 
xsi:schemaLocation="http://www.tei-c.org/ns/1.0 /home/lopez/grobid/grobid-home/schemas/xsd/Grobid.xsd"
 xmlns:xlink="http://www.w3.org/1999/xlink">
	<teiHeader xml:lang="en">
		<fileDesc>
			<titleStmt>
				<title level="a" type="main">A Medicinal Herb Scutellaria lateriflora Inhibits PrP Replication in vitro and Delays the Onset of Prion Disease in Mice</title>
			</titleStmt>
			<publicationStmt>
				<publisher>Frontiers Media SA</publisher>
				<availability status="unknown"><p>Copyright Frontiers Media SA</p>
				</availability>
				<date type="published" when="2012-02-17">17 February 2012.</date>
			</publicationStmt>
			<sourceDesc>
				<biblStruct>
					<analytic>
						<author>
							<persName xmlns="http://www.tei-c.org/ns/1.0"><forename type="first">Martin</forename><surname>Eiden</surname></persName>
						</author>
						<author>
							<persName xmlns="http://www.tei-c.org/ns/1.0"><forename type="first">Fabienne</forename><surname>Leidel</surname></persName>
						</author>
						<author>
							<persName xmlns="http://www.tei-c.org/ns/1.0"><forename type="first">Barbara</forename><surname>Strohmeier</surname></persName>
						</author>
						<author>
							<persName xmlns="http://www.tei-c.org/ns/1.0"><forename type="first">Christine</forename><surname>Fast</surname></persName>
						</author>
						<author role="corresp">
							<persName xmlns="http://www.tei-c.org/ns/1.0"><forename type="first">Martin</forename><forename type="middle">H</forename><surname>Groschup</surname></persName>
							<email>martin.groschup@fli.bund.de</email>
						</author>
						<author>
							<affiliation key="aff0">
								<orgName type="department">Institute for Novel and Emerging Infectious Diseases</orgName>
								<orgName type="institution" key="instit1">Friedrich-Loeffler-Institut</orgName>
								<orgName type="institution" key="instit2">Federal Research Institute for Animal Health</orgName>
								<address>
									<settlement>Greifswald</settlement>
									<country key="DE">Germany</country>
								</address>
							</affiliation>
						</author>
						<author>
							<affiliation key="aff1">
								<orgName type="institution">University of Greifswald</orgName>
								<address>
									<country key="DE">Germany</country>
								</address>
							</affiliation>
						</author>
						<author>
							<affiliation key="aff2">
								<orgName type="department">Anja Brenn, University Medicine</orgName>
								<address>
									<settlement>Greifswald</settlement>
									<country key="DE">Germany</country>
								</address>
							</affiliation>
						</author>
						<author>
							<affiliation key="aff3">
								<orgName type="institution">University of Hamburg Eppendorf UKE</orgName>
								<address>
									<country key="DE">Germany</country>
								</address>
							</affiliation>
						</author>
						<author>
							<affiliation key="aff4">
								<orgName type="department" key="dep1">Institute for Novel and Emerging Infectious Diseases</orgName>
								<orgName type="department" key="dep2">Friedrich-Loeffler-Institut</orgName>
								<address>
									<addrLine>17493 Greifswald-Insel Riems</addrLine>
									<country key="DE">Germany</country>
								</address>
							</affiliation>
						</author>
						<title level="a" type="main">A Medicinal Herb Scutellaria lateriflora Inhibits PrP Replication in vitro and Delays the Onset of Prion Disease in Mice</title>
					</analytic>
					<monogr>
						<title level="j" type="main">Frontiers in Psychiatry</title>
						<title level="j" type="abbrev">Front. Psychiatry</title>
						<idno type="eISSN">1664-0640</idno>
						<imprint>
							<publisher>Frontiers Media SA</publisher>
							<biblScope unit="volume">3</biblScope>
							<date type="published" when="2012-02-17">17 February 2012.</date>
						</imprint>
					</monogr>
					<idno type="DOI">10.3389/fpsyt.2012.00009</idno>
					<idno type="PMID">22363300</idno>
					<idno type="PMCID">PMC3281244</idno>
					<ptr type="open-access" target="https://www.frontiersin.org/articles/10.3389/fpsyt.2012.00009/pdf" />
					<note type="submission">Received: 12 December 2011; paper pending published: 30 December 2011; accepted: 02 February 2012;</note>
				</biblStruct>
			</sourceDesc>
		</fileDesc>
		<encodingDesc>
			<appInfo>
				<application version="0.6.2-SNAPSHOT" ident="GROBID" when="2020-08-13T22:00+0000">
					<desc>GROBID - A machine learning software for extracting information from scholarly documents</desc>
					<ref target="https://github.com/kermitt2/grobid"/>
				</application>
			</appInfo>
		</encodingDesc>
		<profileDesc>
			<textClass>
				<keywords>
					<term>prion protein</term>
					<term>inhibitor</term>
					<term>Scutellaria lateriflora</term>
					<term>baicalein</term>
					<term>baicalin Scutellaria lateriflora inhibits prion replication</term>
				</keywords>
			</textClass>
			<abstract>
				<p>Transmissible spongiform encephalopathies (TSE) are characterized by the misfolding of the host encoded prion protein (PrP C) into a pathogenic isoform (PrP Sc) which leads to the accumulation of Î²-sheet-rich fibrils and subsequent loss of neurons and synaptic functions. Although many compounds have been identified which inhibit accumulation or dissolve fibrils and aggregates in vitro there is no therapeutic treatment to stop these progressive neurodegenerative diseases. Here we describe the effects of the traditional medicinal herb Scutellaria lateriflora (S. lateriflora) and its natural compounds, the flavonoids baicalein and baicalin, on the development of prion disease using in vitro and in vivo models. S. lateriflora extract as well as both constituents reduced the PrP res accumulation in scrapie-infected cell cultures and cell-free conversion assays and lead to the destabilization of pre-existing PrP Sc fibrils. Moreover, tea prepared from S. lateriflora, prolonged significantly the incubation time of scrapie-infected mice upon oral treatment. Therefore S. lateriflora extracts as well as the individual compounds can be considered as promising candidates for the development of new therapeutic drugs against TSEs and other neurodegenerative diseases like Alzheimer&apos;s and Parkinson&apos;s disease.</p>
			</abstract>
		</profileDesc>
	</teiHeader>
	<text xml:lang="en">
		<body>
<div xmlns="http://www.tei-c.org/ns/1.0"><head>INTRODUCTION</head><p>Transmissible spongiform encephalopathies (TSEs) are neurodegenerative diseases which are characterized by the accumulation and deposition of a pathogenic isoform (PrP Sc ) of the host encoded cellular prion protein (PrP C ) designated PrP Sc . Both isoforms share the same amino acid sequence but differ in conformation, resistance to proteinase K (PK), and pathogenicity. PrP Sc tends to oligomerize by a seeded polymerization mechanism followed by the formation of multimers and eventually of fibril structures. This aggregation can be reproduced in an analogous manner in vitro, using cell-based as well as cell-free assays. The evolved PrP Sc like isoforms -termed PrP res -harbor similar biochemical characteristics like resistance to Proteinase K and detection by same antibodies.</p><p>Accumulation of PrP Sc in the central nervous system (CNS) is accompanied by neurological dysfunctions, neuronal vacuolation, and astrocytic gliosis. Although the exact disease causing mechanism is unknown to date, there is evidence for a general neurotoxicity of these aggregates, which deteriorate synaptic function and induce oxidative stress and membrane disruption <ref type="bibr" target="#b37">(Soto and Estrada, 2008)</ref>. Prion diseases belong to the group of protein misfolding diseases like Alzheimer's (AD), Parkinson's (PD), and Huntington's disease (HD), which are generally characterized by an incorrect folding process of a host encoded protein with a conformation different from its native structure. The misfolding is followed by a self-aggregation and polymerization of the protein according to a "seeding-nucleation" process <ref type="bibr" target="#b18">(Jarrett and Lansbury, 1993)</ref>.</p><p>As PrP Sc formation and aggregation is the central event in prion diseases, the inhibition of oligomer formation and fibril extension as well as the enhancement of fibril degradation are major targets for the development of therapeutic strategies against TSEs. Several substances have been identified which inhibit PrP res formation and accumulation in vitro and prolonged survival in scrapie-infected animals: Congo red <ref type="bibr" target="#b2">(Caughey and Race, 1992)</ref>, branched polyamines <ref type="bibr" target="#b38">(Supattapone et al., 2001)</ref>, porphyrins and phthalocyanines <ref type="bibr" target="#b31">(Priola et al., 2000;</ref><ref type="bibr" target="#b4">Caughey et al., 2007)</ref>, heparan sulfate mimetics <ref type="bibr" target="#b0">(Adjou et al., 2003)</ref>, amphotericin <ref type="bibr" target="#b28">(Mange et al., 2000)</ref>, curcumine <ref type="bibr" target="#b3">(Caughey et al., 2003;</ref><ref type="bibr" target="#b44">Yang et al., 2009)</ref>, and tetracyclines <ref type="bibr" target="#b5">(De Luigi et al., 2008)</ref>. However, for various reasons none of these compounds has been included in prevention and treatment regimes for humans yet. Most recently two new substance classes, benzothiazoles <ref type="bibr" target="#b11">(Geissen et al., 2011)</ref> and diphenylpyrazoles <ref type="bibr" target="#b24">(Leidel et al., 2011)</ref>, were identified by high-throughput screening approaches that inhibit PrP res accumulation in cell culture models and prolong incubation times in scrapie-infected mice.</p><p>Other therapeutic strategies rely on passive immunization <ref type="bibr" target="#b43">(White et al., 2003)</ref>, RNA interference <ref type="bibr" target="#b30">(Pfeifer et al., 2006)</ref>, RNA aptamers <ref type="bibr" target="#b32">(Proske et al., 2002)</ref>, copper chelating antibiotics <ref type="bibr" target="#b29">(Murakami-Kubo et al., 2004)</ref>, or on the induction of autophagy by Lithium <ref type="bibr" target="#b16">(Heiseke et al., 2009)</ref>.</p><p>Recent studies on AD suggest that phenolic compounds like green tea epigallocatechin gallate <ref type="bibr" target="#b33">(Rezai-Zadeh et al., 2005)</ref>, herb extracts like grape seed polyphenolic extract <ref type="bibr" target="#b42">(Wang et al., 2009;</ref><ref type="bibr" target="#b26">Liu et al., 2011)</ref>, or medicinal herbs like Paeonia suffruticosa <ref type="bibr" target="#b10">(Fujiwara et al., 2009)</ref> can be used for the treatment of neurodegenerative diseases.</p><p>The here presented study shows that the American skullcap Scutellaria lateriflora, a traditional medical herb in North America, exhibits strong anti-prion activity. Extracts of this plant have been traditionally used as sedative and for the treatment of insomnia, anxiety, or neuralgia <ref type="bibr" target="#b8">(Foster, 1996)</ref>. Moreover, we can show here that the crude aqueous extract inhibits prion propagation and dissolves prion aggregates in vitro. Continuous oral administration of S. lateriflora tea (water extract) significantly prolonged incubation times in scrapie-infected mice. Notably, the natural constituents, the flavonoids baicalein and baicalin-hydrate, exhibit the same inhibitory effects on prion propagation and dissolve existing fibrils.</p></div>
<div xmlns="http://www.tei-c.org/ns/1.0"><head>MATERIALS AND METHODS</head></div>
<div xmlns="http://www.tei-c.org/ns/1.0"><head>FLAVONOIDS AND TEA OF SCUTELLARIA LATERIFLORA</head><p>Baicalein and baicalein-hydrate were purchased from Sigma-Aldrich and solubilized in DMSO. The dried herb S. lateriflora was purchased from Goldener Zweig (Buchholz, Germany). Water extracts (tea) were prepared by mixing 30 g of sliced dry herbs in 1.0 l boiling water for 30 min. After cooling the tea was administered directly to mice. For in vitro experiments tea was lyophilized to yield dried extracts. In cell-based assays the dried material was resuspended in H 2 O, concentrated by a factor of 10 (termed tea concentrate) and added to the cell culture medium. In cell-free conversion assay the dried extract was directly resuspended in the conversion buffer in a final volume of 20 Î¼l.</p></div>
<div xmlns="http://www.tei-c.org/ns/1.0"><head>PROPAGATION OF SCRAPIE STRAINS</head><p>C57Bl/6 mice were inoculated with cloned mouse scrapie strains RML intracerebrally (i.c.; 30 Î¼l of 1% mouse brain homogenate) or intraperitoneally (i.p.; 50 Î¼l of 1% brain homogenate). The health status of the mice was inspected daily, and their body weights were recorded weekly. After the onset of TSE-associated clinical symptoms (and weight loss, abnormal tail tonus, hind limb paralysis), the animals were euthanized. The incubation times were calculated as the time between inoculation and death. The brains were removed and kept as following: one half of each brain was stored at â20ËC, and the other half was fixed in 4% neutral buffered formalin.</p><p>Pathogenic isoform for PrP conversion reactions was purified from brains of C57/Bl6 mice i.c. inoculated with mouse scrapie strain Me7. Brains were taken at the beginning of clinical symptoms in the animals and stored at â20ËC. PrP Sc was purified according to <ref type="bibr" target="#b7">Eiden et al. (2006)</ref>.</p></div>
<div xmlns="http://www.tei-c.org/ns/1.0"><head>HEMATOXYLIN AND EOSIN STAINING AND IMMUNOHISTOCHEMISTRY</head><p>Before embedding in paraffin the formalin fixed brain was cut at five different levels to reveal caudal medulla, rostral medulla, midbrain, thalamic, and frontal slices. Lesion profile scoring was carried out on Hematoxylin and Eosin (H&amp;E) stained sections according to standard methodology <ref type="bibr" target="#b9">(Fraser and Dickinson, 1968)</ref>. For immunohistochemistry samples were processed (with minor modifications) as described previously <ref type="bibr" target="#b15">(Hardt et al., 2000)</ref>. Three micrometers section were de-paraffinized and rehydrated. Pretreatment included an incubation step with 98% formic acid (15 min) and blocking of the endogenous peroxidase activity with 3% H 2 O 2 /methanol (30 min) followed by autoclaving in citrate buffer (pH 6.0, 20 min). The monoclonal antibody SAF 84 was applied at a dilution of 1:2000 for 2 h at room temperature and detected by avidin-biotin-horseradish peroxidase (Vector Elite). Color reactions were finally developed using diaminobenzidine (DAB) substrate.</p></div>
<div xmlns="http://www.tei-c.org/ns/1.0"><head>PROTEINASE K DIGESTION AND SODIUM PHOSPHOTUNGSTIC ACID PRECIPITATION</head><p>Mouse brain samples 10% (w/v) were prepared in lysis buffer (0.42 mM sucrose solution containing 0.5% deoxycholic acid sodium salt (DOC) and 0.5% Non-idet P40) and incubated with PK (50 Î¼g/ml, final concentration) for 60 min at 55ËC. Reactions were stopped with pefabloc (Roche) followed by incubation with 0.3% (w/v) phosphotungstic acid precipitation (PTA) and selective precipitation of PrP Sc according to <ref type="bibr" target="#b12">Gretzschel et al. (2005)</ref>.</p></div>
<div xmlns="http://www.tei-c.org/ns/1.0"><head>PRP CONVERSION REACTION</head><p>Cell-free conversion studies were performed as described before <ref type="bibr" target="#b7">(Eiden et al., 2006;</ref><ref type="bibr" target="#b23">Kupfer et al., 2007)</ref>. For the conversion reaction 400 ng of recombinant ovine PrP C , expressed in E. coli, was incubated with 200-400 ng of purified PrP Sc in a conversion buffer [50 mM citrate buffer (pH 6.0), 200 mM KCl, 5 mM MgCl 2 , and 1.25% sarkosyl; <ref type="bibr" target="#b17">Horiuchi et al., 2000]</ref>. Standard conversion reactions were carried out for 3 days at 37ËC. Afterward, samples were incubated with PK (final concentration of 30 Î¼g/ml) for 1 h at 37ËC. PK was diluted in TN-buffer (0.15 M NaCl, 0.05 M Tris/HCl pH 7.4). The reaction was stopped with PMSF (phenyl methansulfonyl fluoride; 10 mM). Twenty micrograms of a carrier protein (thyroglobulin) was added and the samples were incubated with a fourfold volume of methanol at -20ËC to precipitate the proteins. After centrifugation at 12000 g for 15 min, the proteins were pelleted and resolubilized by heating to 95ËC for 5 min in SDS-PAGE loading buffer [1% (w/v) SDS, 25 mM Tris/HCl pH 7.4, 0.5% mercaptoethanol, and 0.001% bromophenol blue].</p><p>Samples were separated on SDS-polyacrylamide gels containing 16% (w/v) acrylamide/bisacrylamide, 0.375 M Tris/HCl (pH 8.8), 0.5% (w/v) SDS (sodium dodecyl sulfate), 0.06% (w/v) APS (ammonium peroxydisulfate), and 0.06%</p><formula xml:id="formula_0">(v/v) TEMED (N,N,N ,N -tetramethylethylenediamine) with a 4% stacking gel [4% (w/v) acrylamide/bisacrylamide, 0.12 M Tris/HCl (pH 6.8), 0.5% (w/v) SDS, 0.2% APS, 0.2% (v/v) TEMED].</formula><p>For immunoblotting proteins were transferred in a semidry chamber to a polyvinylidene difluoride (PVDF) membrane. Membranes were then incubated in blocking buffer (PBS-0.1% Tween 20, 5% non-fat dry milk powder) followed by incubation for 60 min with the monoclonal antibody (mab) P4 (R-Biopharm), mab SAF-70 (SPIbio), or polyclonal antibody (pab) Ra 10 <ref type="bibr" target="#b14">(Groschup et al., 1994</ref><ref type="bibr" target="#b13">(Groschup et al., , 1997</ref>. In contrast to mab P4, which detects ovine PrP C/res , pab Ra10 detects only murine PrP C/Sc . Membranes were washed three times for 10 min with PBS containing 0.1% Tween 20 and then incubated with a secondary antibody bound to alkaline phosphatase (Goat-anti-mouse-alkaline phosphatase or goat anti-rabbit-peroxidase). After washing, the chemiluminescence substrate CDP-Star (Tropix) was applied and membranes were incubated for 5 min before the light signals were Frontiers in Psychiatry | Neurodegeneration recorded on a Versadoc Imaging System (Biorad). Visualization was carried out with the Biorad VersaDocâ¢quantification software Quantity One. The percentage of converted substrate was calculated as: signal volume of PrP res digested with PK/signal volume of PrP C without PK * 10. Conversion rates were calculated for each time point as a mean value from four independent reactions. For stripping, membranes were incubated twice for 15 min with a buffer containing 0.2 M glycine (pH 2.0) and 1% SDS.</p></div>
<div xmlns="http://www.tei-c.org/ns/1.0"><head>PRP RES DETECTION FROM CELL CULTURE</head><p>Two scrapie-infected mouse cell lines were used: ScN 2 Acells [RML infected neuroblastoma-(N 2 A)-cells] and SMB-cells ("scrapie-mouse-brain," infected with strain 22F, a gift of TSE Resource Centre at the Institute for Animal Health, UK). ScN 2 Acells were cultured in Opti-MEM, 10% fetal calf serum (FCS), and 5% CO 2 at 37ËC. SMB-cells were cultured in MEM+ [MEM199, 10% newborn calf serum (NCS), 5% FCS] and 5% CO 2 at 35ËC.</p><p>The cell-based assay was carried out according to <ref type="bibr" target="#b24">Leidel et al. (2011)</ref> with two scrapie-infected mouse cell lines: ScN 2 A-cells and SMB-cells. These cells were adapted for dot blot procedure in 96-well plate format to identify potential inhibitors of PrP Sc formation. Compounds were resolved in DMSO and added to cells in eight replicates in concentrations of 10, 100, and 1000 Î¼M (final concentration). After 3 days of incubation in a CO 2 -incubator, the supernatants were removed and cells lysed in 100 Î¼l lysis buffer (50 mM Tris/HCl, 150 mM NaCl, 0.5% Na-deoxycholate, 0.5% TX-100, pH 8.0). Lysates were or electrophoresed and immunoblotted as described in the previous section or dot blotted on PVDF membranes using a 96-well dot blot apparatus (Transblotter, Roth). Dot blotting membranes were dried for 1 h at 37ËC and fixed sample incubated with DNAse (100 Î¼g/ml) for 1 h at 37ËC. After rinsing the membranes twice with distilled water, the membrane was incubated with PK (25 Î¼g/ml) for 90 min at 37ËC. The digestion was terminated using PMSF (2 mM) and membranes were rinsed in 3 M guanidium thiocyanate for 10 min followed by washing them five times in distilled water.</p><p>The incubation of the membrane with blocking buffer (PBS-0.1% Tween 20, 5% non-fat dry milk powder) was followed by an incubation for 60 min with polyclonal antibody (pab) Ra 10. Membranes were washed three times for 10 min with PBS containing 0.1% Tween 20 and then incubated with a secondary antibody bound to peroxidase (Goat anti-rabbit-PO). Afterward, the chemiluminescence substrate ECL (Roche) was applied and incubated on the membrane for 1 min before the light signals on the membrane were detected directly in a camera. The intensity of the PrP Sc signal of each well was quantified by using the Versadoc imaging system. The half maximal (50%) inhibitory concentration (IC 50 ) of each compound was calculated from eight independent reactions.</p></div>
<div xmlns="http://www.tei-c.org/ns/1.0"><head>STATISTICAL ANALYSIS</head><p>Survival times were analyzed by Kaplan-Meier Survival analysis using the log-rank test to compare the curves. The Statistical analysis was done using SigmaBlot statistical software (San Jose, CA, USA). Survival times are expressed as mean Â± SD.</p></div>
<div xmlns="http://www.tei-c.org/ns/1.0"><head>RESULTS</head><p>The effect of S. lateriflora tea on the PrP res formation was first analyzed in vitro using two different scrapie-infected cell lines (SMB and ScN 2 A-cells), which permanently accumulate PrP res . When tea concentrate was added to the culture medium, a dose dependent reduction of PrP res accumulation was observed in SMB as well as ScN 2 A-cells <ref type="figure" target="#fig_0">(Figure 1)</ref>. Cells were cultivated in T25 flasks and incubated with increasing amounts of S. lateriflora tea for 3 days. After this time, cells were harvested and the level of PK-resistant PrP res was assessed by Western blotting. A dilution of 1:500 induced a reduction of PrP res to 58% for ScN 2 A ( <ref type="figure" target="#fig_0">Figure 1A, lane 2)</ref> and to 64% for SMB ( <ref type="figure" target="#fig_0">Figure 1B, lane 2)</ref> cells compared to the control <ref type="figure" target="#fig_0">(Figures 1A,B, lane 1)</ref>. Dilutions of 1:50 resulted in a reduction to 33% for ScN 2 A-cells ( <ref type="figure" target="#fig_0">Figure 1A, lane  3)</ref> and 57% for SMB-cells ( <ref type="figure" target="#fig_0">Figure 1B, lane 3)</ref>. About 1:20 dilutions displayed reduction to 28% for ScN 2 A ( <ref type="figure" target="#fig_0">Figure 1A, lane 4)</ref> and 47% for SMB-cells ( <ref type="figure" target="#fig_0">Figure 1B, lane 4)</ref> and reached values of 28.7% for ScN 2 A-cells ( <ref type="figure" target="#fig_0">Figure 1A, lane 5)</ref> and 42.3% for SMBcells ( <ref type="figure" target="#fig_0">Figure 1B, lane 5)</ref>. Relative inhibition by tea is depicted in <ref type="figure" target="#fig_0">Figure 1C</ref>.</p><p>To test the direct effects of tea on the conversion of PrP C to PrP res , a cell-free conversion assay was used in which a purified murine PrP Sc template induced the conversion of recombinant cellular PrP C into a PK-resistant PrP res fragment <ref type="bibr" target="#b7">(Eiden et al., 2006;</ref><ref type="bibr" target="#b23">Kupfer et al., 2007)</ref>. Newly converted PrP res -fragments were detected by mab P4 <ref type="figure" target="#fig_0">(Figure 2A, lanes 1-2)</ref>, while PrP Sc aggregates were visualized by the polyclonal antibody Ra10 <ref type="figure" target="#fig_0">(Figure 2B,  lanes 1-2)</ref>. Dried tea extract (3, 0.3, and 0.03 mg respectively) was added to the conversion assay, inhibited PrP res formation and led to clearance of PrP res -fragments <ref type="figure">(Figure 2A, lanes 3-6)</ref>. Even 0.03 mg caused a reduced PrP res formation compared to the control <ref type="figure">(Figure 2A, lanes 7-8)</ref> by 23%.</p><p>Similar results were seen in the case of dissolution of PrP Sc aggregates after PK digestion ( <ref type="figure">Figure 2B)</ref>. In contrast to the control ( <ref type="figure" target="#fig_0">Figure 2B, lanes 1-2)</ref>, PrP Sc aggregates were completely digested if co-incubated with 3.0 mg dried tea extract ( <ref type="figure" target="#fig_2">Figure 2B,  lanes 3-4)</ref>, as well as with 0.3 mg ( <ref type="figure" target="#fig_3">Figure 2B, lanes 5-6)</ref>. About 0.03 mg dried tea extract induced a partial disaggregation of PrP Sc aggregates ( <ref type="figure">Figure 2B, lanes 7-8)</ref> by 40% compared to the control.</p><p>To further characterize the underlying inhibitory mechanisms, two main polyphenolic compounds of this herbal extract, the flavonoids Baicalin (baicalein 7-O-glucuronide) and its aglycone baicalein (5,6,7-trihydroxyflavone), were studied with regard to their inhibitory properties. Both components have been isolated from this herb previously <ref type="bibr" target="#b1">(Awad et al., 2003)</ref> und were also identified in this study as ingredients in the tea by LCMS-IT-TOF hybrid mass spectrometry (data not shown). In addition, a structural analog to baicalein, the flavonoid epicatechin and quercetin were analyzed.</p><p>The potentially inhibitory effects on the PrP res accumulation and conversion were assayed by a cell-based dot blot assay system <ref type="bibr" target="#b11">(Geissen et al., 2011)</ref> and the cell-free conversion assay. Structures, assay results, and half maximal (50%) inhibitory concentrations (IC 50 ) of both compounds are summarized in <ref type="table" target="#tab_0">Table 1</ref>. The cell-based dot blot assay was carried out with two different scrapie-infected SMB and ScN 2 A-cells again. Cells were seeded in 96 wells and incubated with decreasing concentrations of the corresponding flavonoids (1 mM, 100 and 10 Î¼M). IC 50 values of Baicalein ranged from 138 Î¼M (SMB-cells) to 63.7 Î¼M (ScN 2 Acells). Baicalin showed significantly lower inhibitory effects compared to baicalein in SMB-cells (IC 50 : &gt;1000 Î¼M) as well as in ScN 2 A-cells (IC 50 : 239.8 Î¼M). Two additional flavonoids with similar structure, epicatechin, and quercetin, showed also strong inhibitory effects in both cell-types: epicatechin IC 50 values were 96.6 Î¼M (ScN 2 A-cells) and 106.8 Î¼M (SMB-cells) and quercetin IC 50 values were 36.8 Î¼M (ScN 2 A-cells) and 274.3 Î¼M (SMB-cells; <ref type="table" target="#tab_0">Table 1</ref>). Baicalein displayed a strong dose dependent inhibitory effects to PrP res formation (IC 50 : 18.48 Î¼M) and dissolution of PrP Sc aggregates (IC 50 : 41.56 Î¼M) in the cell-free conversion assay, in contrast to baicalin which yielded IC 50 values of &gt;1000 Î¼M for PrP res inhibition and 440 Î¼M for PrP Sc dissolution. Epicatechin and quercetin, although highly similar in structural to baicalein, showed no inhibitory effects in cell-free conversion with regards to PrP res formation and PrP Sc disintegration.</p><p>In summary, these data demonstrate that tea of S. lateriflora contains two active compounds, baicalein and baicalin, which are specific inhibitors of PrP C conversion and PrP res amplification in vitro as well as enhance the degradation of PrP Sc fibrils.</p><p>In another set of experiments in vivo effects of S. lateriflora tea were assessed. Wild-type mice were infected either by intracerebrally (i.c.) or intraperitoneally (i.p.) inoculation with mouse scrapie strain RML and the drinking water was replaced by freshly brewed tea starting 2 weeks prior to their inoculation and for the whole lifetime of the mice. Survival times are depicted in <ref type="figure">Figure 3</ref>. Six Bl6/C57 mice were used for the treatment and compared to six intracerebrally inoculated mice which received normal drinking water. The mean life spans of the control group <ref type="figure" target="#fig_3">(Figure 5A, bold line)</ref> was 147 Â± 3.1 dpi <ref type="figure">(Figure 3B)</ref> whereas the tea treated mice <ref type="figure" target="#fig_3">(Figure 5A dashed line)</ref> survived significantly longer (184 Â± 26.7 dpi; <ref type="figure">Figure 3B)</ref>. Three of the treated mice survived up to 60 days compared to the control mice. In the case of i.p. inoculation of RML strain, a mean prolongation of 15 days was achieved <ref type="figure">(Figures 3C,D)</ref>. The mean incubation time of the control group <ref type="figure">(Figure 3C, bold line)</ref> was 191 Â± 8.6 dpi ( <ref type="figure">Figure 3D)</ref> whereas the tea treated mice <ref type="figure">(Figure 3C, dashed line)</ref> survived significantly longer (206 Â± 8.6 dpi; <ref type="figure">Figure 3D)</ref>.</p><p>Brains of the i.c. infected mice were subjected to comparative biochemical and immunohistochemical investigations. PrP immunoblot analysis revealed no differences of PrP Sc banding patterns and total amounts of PrP Sc in both groups. The PrP Sc content in all brains was analyzed after PK digestion and selective precipitation of PrP Sc from corresponding mouse brain homogenates with sodium phosphotungstic acid <ref type="figure" target="#fig_2">(Figure 4)</ref>. No differences</p></div>
<div xmlns="http://www.tei-c.org/ns/1.0"><head>FIGURE 2 | Western blot analysis of inhibition of PrP res formation and disaggregation of pre-existing PrP Sc fibrils in a cell-free conversion assay. (A)</head><p>Tea of S. lateriflora inhibits formation of PrP res . Lanes 1-2 show PK-resistant PrP res -fragments in samples without tea, lanes 3-4 samples after co-incubation with 3.0 mg dried tea extract, lanes 5-6 with 0.3 mg dried tea extract, and lanes 7-8 co-incubation with 0.03 mg dried tea extract. Detection was carried out with mab P4. (B) Tea of S. lateriflora disaggregates pre-existing fibrils after digestion with PK. The membrane from (A) was stripped and incubated another time with pab Ra10. Lanes 1-2 show PK-resistant PrP res -fragments in samples without tea, lanes 3-4 samples after co-incubation with 3.0 mg dried tea extract, lanes 5-6 with 0.3 mg dried tea extract, and lanes 7-8 co-incubation with 0.03 mg dried tea extract. Western blot was analyzed by standard chemiluminescence method. +: incubation with proteinase K (PK).</p><p>in PrP Sc banding patterns or PK resistances was detected in mice which eventually developed scrapie in the tea treated and control group <ref type="figure" target="#fig_0">(Figure 4, lanes 2-13)</ref>. The brain lesion profiles and PrP Sc deposition patterns in the different mouse brain regions were similar for the treated and the untreated mice <ref type="figure" target="#fig_3">(Figures 5A-D)</ref>.</p></div>
<div xmlns="http://www.tei-c.org/ns/1.0"><head>DISCUSSION</head><p>The here presented study demonstrates that solubilized ingredients of S. lateriflora not only inhibit the scrapie fibril formation but also destabilize pre-formed PrP Sc fibrils in a concentration dependent manner. Main constituents of the herb were the polyphenolic flavonoids baicalin and baicalein, which were found at high concentrations in corresponding extracts. Both components in purified form showed dose dependent inhibitory properties and thus were the active constituents responsible for the herbs effects on scrapie fibril regulation.</p><p>The strongest effects displayed baicalein, the main metabolite of baicalin, which inhibited PrP res accumulation in both cell-based and cell-free assays and promoted the destabilization of PrP Sc fibrils at low concentrations. A possible molecular mechanism is based on direct binding to the PrP C and the formation of a stable PrP-baicalein/baicalin complex, which blocks PrP conversion and/or accumulation. In the same way the destabilization of pre-existing fibrils would be caused by a specific intercalation of baicalein/baicalin into Î²-sheet structures of the PrP Sc aggregates which may lead to a forced PrP Sc degradation by lysosomal proteases. Similar effects by Baicalein have been described for the inhibition of Î±-synuclein <ref type="bibr" target="#b45">(Zhu et al., 2004)</ref> and amyloid-Î² peptide (AÎ²) fibrillization <ref type="bibr" target="#b27">(Lu et al., 2011)</ref>.   PrP Sc from RML infected mouse brains and lanes 8-13 PrP Sc from RML infected mouse brains that were treated with tea from S. lateriflora. Western blot was carried out with pab Ra10 and analyzed by chemiluminescence method.</p><p>In our present study oral administration of S. lateriflora tea significantly prolonged incubation of mice either infected intracerebral or intraperitoneal. These effects can be explained by direct interference of baicalein to evolving PrP aggregates in the CNS. Baicalein is able to cross the blood brain barrier and ultimately reach the CNS <ref type="bibr" target="#b40">(Tsai et al., 2002)</ref>. Baicalin, on the other hand, may act as pro-drug: After oral uptake, the sugar residue is cleaved by enzymes in the intestinal tract to generate baicalein. The more lipophilic baicalein is better absorbed in the gastrointestinal tract and can then enter the brain via the blood system <ref type="bibr" target="#b39">(TarragÃ³ et al., 2008)</ref>.</p><p>Within the CNS, the inhibition and dissolution of prion aggregates by Baicalein could protect neuronal cells from membrane disruption and subsequent neuronal cell death. Additional antioxidant properties of baicalein on reactive oxygen species (ROS), which evolve during protein aggregation, may reinforce this neuroprotective effect <ref type="bibr" target="#b25">(Li et al., 2010)</ref>. Baicalein is able to minimize ROS by directly quenching free radicals or indirectly inducing antioxidant enzymes like superoxide dismutase and catalase <ref type="bibr" target="#b36">(Shieh et al., 2000;</ref><ref type="bibr" target="#b19">Kang et al., 2011)</ref>.</p><p>Direct effects on the prion conversion were also seen in other plant derived polyphenols like curcumin which is a strong inhibitor of prion conversion replication in vitro <ref type="bibr" target="#b3">(Caughey et al., 2003)</ref>. It is in vivo efficacy, however, remains controversial: the oral administration of curcumin had no significant effect on the onset of scrapie in hamsters <ref type="bibr" target="#b3">(Caughey et al., 2003)</ref>, whereas scrapie-infected mice significantly survived longer after oral treatment <ref type="bibr" target="#b35">(Riemer et al., 2008)</ref>. Effects of other polyphenols (e.g., tannic acid, katacine, and 2 -2 -bis epigallocatechin gallate) that interfere with PrP conversion in vitro were also studied in vivo <ref type="bibr" target="#b21">(Kocisko et al., 2003)</ref>. However, neither these substances nor mixtures of natural compounds including polyphenolic tea extract and pine bark extracts displayed any effects on incubation periods in scrapie-infected animals <ref type="bibr" target="#b22">(Kocisko et al., 2004)</ref>.</p><p>Up to now only few compounds have been reported that delay onset on prion diseases after oral treatment. This includes pravastatin <ref type="bibr" target="#b41">(Vetrugno et al., 2009)</ref>, which is involved in cholesterol biosynthesis and influences membrane structure and function, fucoidan <ref type="bibr" target="#b6">(Doh-Ura et al., 2007)</ref>, as well as amyloid dye derivatives <ref type="bibr" target="#b20">(Kawasaki et al., 2007)</ref>. However, possible drug associated sideeffects have to be further evaluated. Recently, diphenyl-pyrazoles <ref type="bibr" target="#b24">(Leidel et al., 2011)</ref> were identified as a new class of anti-prion compounds, which prolong incubation time of scrapie-infected mice even after oral application.</p><p>In conclusion, beneficial effects of S. lateriflora tea can be explained by the anti-aggregatory and potential anti-oxidative effects of its natural constituents, baicalein and baicalin. Only few studies were conducted with herbal extracts of S. lateriflora for prevention and therapy of protein misfolding diseases to date. Results shown here for prion diseases are promising also in the context of other diseases in this group.</p></div><figure xmlns="http://www.tei-c.org/ns/1.0" xml:id="fig_0"><head>FIGURE 1 |</head><label>1</label><figDesc>Western blot analysis of inhibition of PrP res formation in scrapie-infected cells by tea concentrate of S. lateriflora. (A) Tea concentrate of S. lateriflora inhibits PrP res formation in ScN 2 A-cells. Lane 1 shows PK-resistant fragments of the untreated control, lanes 2-5 a sample incubated with increasing concentrations of tea concentrate of S. lateriflora: 1:500 (lane 2), 1:50 (lane 3), 1:20 (lane 4), and 1:10 (lane 5). (B) Inhibition of PrP res formation in SMB-cells by tea concentrate of S. lateriflora. PK-resistant fragments were detected in untreated control (lane 1), after incubation with tea in a 1:500 dilution (lane 2), 1:50 (lane 3), 1:20 and 1:10 (lane 5). Detection was carried out with pab Ra10 and analyzed by standard chemiluminescence method. (C) Relative inhibition (%) of PrP res formation by tea concentrate for SMB (red line) and ScN 2 A (blue line) cells. +, incubation with proteinase K (PK); u.d., undiluted.</figDesc></figure>
<figure xmlns="http://www.tei-c.org/ns/1.0" xml:id="fig_1"><head>February 2012 |FIGURE 3 |</head><label>20123</label><figDesc>Volume 3 | Article 9 | 5 Tea of S. lateriflora prolongs incubation time in scrapie-infected mice after oral treatment. (A) Oral treatment of intracerebrally infected mice: Kaplan-Meier survival analysis of intracerebrally scrapie (RML) infected C57/Bl6 mice after oral treatment with tea of S. lateriflora. Treatment groups consisted of untreated controls ( ), and tea treated mice ( ). (B) Mean survival times in primary efficiency test Â± SD. Comparison of tea versus untreated controls was carried out by log-rank test, p &lt; 0.01( * * ). (C) Oral treatment of intraperitoneally infected mice: Kaplan-Meier survival analysis of intraperitoneally scrapie (RML) infected C57/Bl6 mice after oral treatment tea of S. lateriflora. Treatment groups consisted of untreated controls ( ), and tea treated mice ( ). (D) Mean survival times in primary efficiency test Â± SD. Comparison of tea versus untreated controls, was carried out by log-rank test, p &lt; 0.05( * ).</figDesc></figure>
<figure xmlns="http://www.tei-c.org/ns/1.0" xml:id="fig_2"><head>FIGURE 4 |</head><label>4</label><figDesc>Western blot analysis of sodium phosphotungstic acid precipitation of PrP Sc from brain homogenate of RML infected mice. Proteinase K digested and sodium phosphotungstic acid precipitated PrP Sc was detected by mab SAF-70. Lane 1 shows an uninfected control, lanes 2-7</figDesc></figure>
<figure xmlns="http://www.tei-c.org/ns/1.0" xml:id="fig_3"><head>FIGURE 5 |</head><label>5</label><figDesc>PrP Sc accumulation in the brains of mice challenged with RML. Immunohistochemistry: moderate diffuse PrP Sc accumulation in the cerebral cortex and multifocally in the corpus callosum of both (A) untreated and (B) with tea treated mice. Detection was carried out with mab SAF 84. Bar 200 Î¼m. H&amp;E staining: mild vacuolation in the cerebral cortex of both (C) untreated and (D) with tea treated mice, H&amp;E staining, Bar 200 Î¼m.</figDesc></figure>
<figure xmlns="http://www.tei-c.org/ns/1.0" type="table" xml:id="tab_0"><head>Table 1 | Chemical structures of flavonoids and in vitro analyses.</head><label>1</label><figDesc></figDesc><table><row><cell>Compound</cell><cell>Dot blot</cell><cell cols="2">IC 50 (Î¼M)</cell><cell></cell><cell>Cell-free conversion assay</cell><cell cols="2">IC 50 (Î¼M)</cell></row><row><cell>ScN 2 A</cell><cell>SMB</cell><cell cols="2">ScN 2 A SMB</cell><cell>Prp res</cell><cell>Prp Sc</cell><cell>Prp res</cell><cell>Prp Sc</cell></row><row><cell></cell><cell></cell><cell>63.7</cell><cell>139</cell><cell></cell><cell></cell><cell>18.48</cell><cell>41.56</cell></row><row><cell></cell><cell></cell><cell>239.8</cell><cell>&gt;1000</cell><cell></cell><cell></cell><cell cols="2">&gt;1000 440</cell></row><row><cell></cell><cell></cell><cell>96.9</cell><cell>106.8</cell><cell></cell><cell></cell><cell>n.e.</cell><cell>n.e.</cell></row><row><cell></cell><cell></cell><cell>36.8</cell><cell>274.3</cell><cell></cell><cell></cell><cell>n.e.</cell><cell>n.e.</cell></row><row><cell cols="3">IC 50 , Half maximal (50%) inhibitory concentration; n.e., not effective.</cell><cell></cell><cell></cell><cell></cell><cell></cell></row></table><note>www.frontiersin.org</note></figure>
			<note xmlns="http://www.tei-c.org/ns/1.0" place="foot">February 2012 | Volume 3 | Article 9 | 2</note>
			<note xmlns="http://www.tei-c.org/ns/1.0" place="foot">www.frontiersin.orgFebruary 2012 | Volume 3 | Article 9 | 3</note>
			<note xmlns="http://www.tei-c.org/ns/1.0" place="foot">February 2012 | Volume 3 | Article 9 | 6</note>
		</body>
		<back>

			<div type="acknowledgement">
<div xmlns="http://www.tei-c.org/ns/1.0"><head>ACKNOWLEDGMENTS</head><p>The LCMS-IT-TOF analysis was carried out by Andreas Link and Andrea Bodtke, Institute of Pharmacy, Ernst-Moritz-Arndt-University Greifswald, Greifswald, Germany.</p></div>
			</div>

			<div type="annex">
<div xmlns="http://www.tei-c.org/ns/1.0"><head>Conflict of Interest Statement:</head><p>The authors declare that the research was conducted in the absence of any commercial or financial relationships that could be construed as a potential conflict of interest.</p></div>			</div>
			<div type="references">

				<listBibl>

<biblStruct xml:id="b0">
	<analytic>
		<title level="a" type="main">A novel generation of heparan sulfate mimetics for the treatment of prion diseases</title>
		<author>
			<persName xmlns="http://www.tei-c.org/ns/1.0"><forename type="first">K</forename><forename type="middle">T</forename><surname>Adjou</surname></persName>
		</author>
		<author>
			<persName xmlns="http://www.tei-c.org/ns/1.0"><forename type="first">S</forename><surname>Simoneau</surname></persName>
		</author>
		<author>
			<persName xmlns="http://www.tei-c.org/ns/1.0"><forename type="first">N</forename><surname>Sales</surname></persName>
		</author>
		<author>
			<persName xmlns="http://www.tei-c.org/ns/1.0"><forename type="first">F</forename><surname>Lamoury</surname></persName>
		</author>
		<author>
			<persName xmlns="http://www.tei-c.org/ns/1.0"><forename type="first">D</forename><surname>Dormont</surname></persName>
		</author>
		<author>
			<persName xmlns="http://www.tei-c.org/ns/1.0"><forename type="first">D</forename><surname>Papy-Garcia</surname></persName>
		</author>
		<author>
			<persName xmlns="http://www.tei-c.org/ns/1.0"><forename type="first">D</forename><surname>Barritault</surname></persName>
		</author>
		<author>
			<persName xmlns="http://www.tei-c.org/ns/1.0"><forename type="first">J</forename><forename type="middle">P</forename><surname>Deslys</surname></persName>
		</author>
		<author>
			<persName xmlns="http://www.tei-c.org/ns/1.0"><forename type="first">C</forename><forename type="middle">I</forename><surname>Lasmezas</surname></persName>
		</author>
		<idno type="DOI">10.1099/vir.0.19073-0</idno>
		<idno type="PMID">12917481</idno>
	</analytic>
	<monogr>
		<title level="j">Journal of General Virology</title>
		<title level="j" type="abbrev">Journal of General Virology</title>
		<idno type="ISSN">0022-1317</idno>
		<idno type="ISSNe">1465-2099</idno>
		<imprint>
			<biblScope unit="volume">84</biblScope>
			<biblScope unit="issue">9</biblScope>
			<biblScope unit="page" from="2595" to="2603" />
			<date type="published" when="2003-09-01" />
			<publisher>Microbiology Society</publisher>
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b1">
	<analytic>
		<title level="a" type="main">Phytochemical and biological analysis of Skullcap (Scutellaria lateriflora L.): A medicinal plant with anxiolytic properties</title>
		<author>
			<persName xmlns="http://www.tei-c.org/ns/1.0"><forename type="first">R</forename><surname>Awad</surname></persName>
		</author>
		<author>
			<persName xmlns="http://www.tei-c.org/ns/1.0"><forename type="first">J</forename><forename type="middle">T</forename><surname>Arnason</surname></persName>
		</author>
		<author>
			<persName xmlns="http://www.tei-c.org/ns/1.0"><forename type="first">V</forename><surname>Trudeau</surname></persName>
		</author>
		<author>
			<persName xmlns="http://www.tei-c.org/ns/1.0"><forename type="first">C</forename><surname>Bergeron</surname></persName>
		</author>
		<author>
			<persName xmlns="http://www.tei-c.org/ns/1.0"><forename type="first">J</forename><forename type="middle">W</forename><surname>Budzinski</surname></persName>
		</author>
		<author>
			<persName xmlns="http://www.tei-c.org/ns/1.0"><forename type="first">B</forename><forename type="middle">C</forename><surname>Foster</surname></persName>
		</author>
		<author>
			<persName xmlns="http://www.tei-c.org/ns/1.0"><forename type="first">Z</forename><surname>Merali</surname></persName>
		</author>
		<idno type="DOI">10.1078/0944-7113-00374</idno>
		<idno type="PMID">14692724</idno>
	</analytic>
	<monogr>
		<title level="j">Phytomedicine</title>
		<title level="j" type="abbrev">Phytomedicine</title>
		<idno type="ISSN">0944-7113</idno>
		<imprint>
			<biblScope unit="volume">10</biblScope>
			<biblScope unit="issue">8</biblScope>
			<biblScope unit="page" from="640" to="649" />
			<date type="published" when="2003-01" />
			<publisher>Elsevier BV</publisher>
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b2">
	<analytic>
		<title level="a" type="main">Potent Inhibition of Scrapie-Associated PrP Accumulation by Congo Red</title>
		<author>
			<persName xmlns="http://www.tei-c.org/ns/1.0"><forename type="first">Byron</forename><surname>Caughey</surname></persName>
		</author>
		<author>
			<persName xmlns="http://www.tei-c.org/ns/1.0"><forename type="first">Richard</forename><forename type="middle">E</forename><surname>Race</surname></persName>
		</author>
		<idno type="DOI">10.1111/j.1471-4159.1992.tb09437.x</idno>
		<idno type="PMID">1352803</idno>
	</analytic>
	<monogr>
		<title level="j">Journal of Neurochemistry</title>
		<title level="j" type="abbrev">J Neurochem</title>
		<idno type="ISSN">0022-3042</idno>
		<idno type="ISSNe">1471-4159</idno>
		<imprint>
			<biblScope unit="volume">59</biblScope>
			<biblScope unit="issue">2</biblScope>
			<biblScope unit="page" from="768" to="771" />
			<date type="published" when="1992-08" />
			<publisher>Wiley</publisher>
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b3">
	<analytic>
		<title level="a" type="main">Inhibition of Protease-Resistant Prion Protein Accumulation In Vitro by Curcumin</title>
		<author>
			<persName xmlns="http://www.tei-c.org/ns/1.0"><forename type="first">B</forename><surname>Caughey</surname></persName>
		</author>
		<author>
			<persName xmlns="http://www.tei-c.org/ns/1.0"><forename type="first">L</forename><forename type="middle">D</forename><surname>Raymond</surname></persName>
		</author>
		<author>
			<persName xmlns="http://www.tei-c.org/ns/1.0"><forename type="first">G</forename><forename type="middle">J</forename><surname>Raymond</surname></persName>
		</author>
		<author>
			<persName xmlns="http://www.tei-c.org/ns/1.0"><forename type="first">L</forename><surname>Maxson</surname></persName>
		</author>
		<author>
			<persName xmlns="http://www.tei-c.org/ns/1.0"><forename type="first">J</forename><surname>Silveira</surname></persName>
		</author>
		<author>
			<persName xmlns="http://www.tei-c.org/ns/1.0"><forename type="first">G</forename><forename type="middle">S</forename><surname>Baron</surname></persName>
		</author>
		<idno type="DOI">10.1128/jvi.77.9.5499-5502.2003</idno>
		<idno type="PMID">12692251</idno>
		<idno type="PMCID">PMC153975</idno>
		<ptr type="open-access" target="https://jvi.asm.org/content/77/9/5499.full.pdf" />
	</analytic>
	<monogr>
		<title level="j">Journal of Virology</title>
		<title level="j" type="abbrev">Journal of Virology</title>
		<idno type="ISSN">0022-538X</idno>
		<imprint>
			<biblScope unit="volume">77</biblScope>
			<biblScope unit="issue">9</biblScope>
			<biblScope unit="page" from="5499" to="5502" />
			<date type="published" when="2003-05-01" />
			<publisher>American Society for Microbiology</publisher>
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b4">
	<analytic>
		<title level="a" type="main">Cyclic Tetrapyrrole Sulfonation, Metals, and Oligomerization in Antiprion Activity</title>
		<author>
			<persName xmlns="http://www.tei-c.org/ns/1.0"><forename type="first">W</forename><forename type="middle">S</forename><surname>Caughey</surname></persName>
		</author>
		<author>
			<persName xmlns="http://www.tei-c.org/ns/1.0"><forename type="first">S</forename><forename type="middle">A</forename><surname>Priola</surname></persName>
		</author>
		<author>
			<persName xmlns="http://www.tei-c.org/ns/1.0"><forename type="first">D</forename><forename type="middle">A</forename><surname>Kocisko</surname></persName>
		</author>
		<author>
			<persName xmlns="http://www.tei-c.org/ns/1.0"><forename type="first">L</forename><forename type="middle">D</forename><surname>Raymond</surname></persName>
		</author>
		<author>
			<persName xmlns="http://www.tei-c.org/ns/1.0"><forename type="first">A</forename><surname>Ward</surname></persName>
		</author>
		<author>
			<persName xmlns="http://www.tei-c.org/ns/1.0"><forename type="first">B</forename><surname>Caughey</surname></persName>
		</author>
		<idno type="DOI">10.1128/aac.01599-06</idno>
		<idno type="PMID">17709470</idno>
		<idno type="PMCID">PMC2151414</idno>
		<ptr type="open-access" target="https://aac.asm.org/content/51/11/3887.full.pdf" />
	</analytic>
	<monogr>
		<title level="j">Antimicrobial Agents and Chemotherapy</title>
		<title level="j" type="abbrev">Antimicrobial Agents and Chemotherapy</title>
		<idno type="ISSN">0066-4804</idno>
		<idno type="ISSNe">1098-6596</idno>
		<imprint>
			<biblScope unit="volume">51</biblScope>
			<biblScope unit="issue">11</biblScope>
			<biblScope unit="page" from="3887" to="3894" />
			<date type="published" when="2007-08-20" />
			<publisher>American Society for Microbiology</publisher>
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b5">
	<analytic>
		<title level="a" type="main">The Efficacy of Tetracyclines in Peripheral and Intracerebral Prion Infection</title>
		<author>
			<persName xmlns="http://www.tei-c.org/ns/1.0"><forename type="first">Ada</forename><surname>De Luigi</surname></persName>
		</author>
		<author>
			<persName xmlns="http://www.tei-c.org/ns/1.0"><forename type="first">Laura</forename><surname>Colombo</surname></persName>
		</author>
		<author>
			<persName xmlns="http://www.tei-c.org/ns/1.0"><forename type="first">Luisa</forename><surname>Diomede</surname></persName>
		</author>
		<author>
			<persName xmlns="http://www.tei-c.org/ns/1.0"><forename type="first">Raffaella</forename><surname>Capobianco</surname></persName>
		</author>
		<author>
			<persName xmlns="http://www.tei-c.org/ns/1.0"><forename type="first">Michela</forename><surname>Mangieri</surname></persName>
		</author>
		<author>
			<persName xmlns="http://www.tei-c.org/ns/1.0"><forename type="first">Claudia</forename><surname>Miccolo</surname></persName>
		</author>
		<author>
			<persName xmlns="http://www.tei-c.org/ns/1.0"><forename type="first">Lucia</forename><surname>Limido</surname></persName>
		</author>
		<author>
			<persName xmlns="http://www.tei-c.org/ns/1.0"><forename type="first">Gianluigi</forename><surname>Forloni</surname></persName>
		</author>
		<author>
			<persName xmlns="http://www.tei-c.org/ns/1.0"><forename type="first">Fabrizio</forename><surname>Tagliavini</surname></persName>
		</author>
		<author>
			<persName xmlns="http://www.tei-c.org/ns/1.0"><forename type="first">Mario</forename><surname>Salmona</surname></persName>
		</author>
		<idno type="DOI">10.1371/journal.pone.0001888</idno>
		<idno type="PMID">18365024</idno>
		<idno type="PMCID">PMC2268013</idno>
		<ptr type="open-access" target="https://journals.plos.org/plosone/article/file?id=10.1371/journal.pone.0001888&amp;type=printable" />
	</analytic>
	<monogr>
		<title level="j">PLoS ONE</title>
		<title level="j" type="abbrev">PLoS ONE</title>
		<idno type="ISSNe">1932-6203</idno>
		<imprint>
			<biblScope unit="volume">3</biblScope>
			<biblScope unit="issue">3</biblScope>
			<biblScope unit="page">e1888</biblScope>
			<date type="published" when="2008-03-26" />
			<publisher>Public Library of Science (PLoS)</publisher>
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b6">
	<analytic>
		<title level="a" type="main">Prophylactic Effect of Dietary Seaweed Fucoidan against Enteral Prion Infection</title>
		<author>
			<persName xmlns="http://www.tei-c.org/ns/1.0"><forename type="first">K</forename><surname>Doh-Ura</surname></persName>
		</author>
		<author>
			<persName xmlns="http://www.tei-c.org/ns/1.0"><forename type="first">T</forename><surname>Kuge</surname></persName>
		</author>
		<author>
			<persName xmlns="http://www.tei-c.org/ns/1.0"><forename type="first">M</forename><surname>Uomoto</surname></persName>
		</author>
		<author>
			<persName xmlns="http://www.tei-c.org/ns/1.0"><forename type="first">K</forename><surname>Nishizawa</surname></persName>
		</author>
		<author>
			<persName xmlns="http://www.tei-c.org/ns/1.0"><forename type="first">Y</forename><surname>Kawasaki</surname></persName>
		</author>
		<author>
			<persName xmlns="http://www.tei-c.org/ns/1.0"><forename type="first">M</forename><surname>Iha</surname></persName>
		</author>
		<idno type="DOI">10.1128/aac.00917-06</idno>
		<idno type="PMID">17438058</idno>
		<idno type="PMCID">PMC1891374</idno>
		<ptr type="open-access" target="https://aac.asm.org/content/51/6/2274.full.pdf" />
	</analytic>
	<monogr>
		<title level="j">Antimicrobial Agents and Chemotherapy</title>
		<title level="j" type="abbrev">Antimicrobial Agents and Chemotherapy</title>
		<idno type="ISSN">0066-4804</idno>
		<idno type="ISSNe">1098-6596</idno>
		<imprint>
			<biblScope unit="volume">51</biblScope>
			<biblScope unit="issue">6</biblScope>
			<biblScope unit="page" from="2274" to="2277" />
			<date type="published" when="2007-04-16" />
			<publisher>American Society for Microbiology</publisher>
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b7">
	<analytic>
		<title level="a" type="main">Synergistic and strain-specific effects of bovine spongiform encephalopathy and scrapie prions in the cell-free conversion of recombinant prion protein</title>
		<author>
			<persName xmlns="http://www.tei-c.org/ns/1.0"><forename type="first">M</forename><surname>Eiden</surname></persName>
		</author>
		<author>
			<persName xmlns="http://www.tei-c.org/ns/1.0"><forename type="first">G</forename><forename type="middle">J</forename><surname>Palm</surname></persName>
		</author>
		<author>
			<persName xmlns="http://www.tei-c.org/ns/1.0"><forename type="first">W</forename><surname>Hinrichs</surname></persName>
		</author>
		<author>
			<persName xmlns="http://www.tei-c.org/ns/1.0"><forename type="first">U</forename><surname>Matthey</surname></persName>
		</author>
		<author>
			<persName xmlns="http://www.tei-c.org/ns/1.0"><forename type="first">R</forename><surname>Zahn</surname></persName>
		</author>
		<author>
			<persName xmlns="http://www.tei-c.org/ns/1.0"><forename type="first">M</forename><forename type="middle">H</forename><surname>Groschup</surname></persName>
		</author>
		<idno type="DOI">10.1099/vir.0.81590-0</idno>
		<idno type="PMID">17098995</idno>
	</analytic>
	<monogr>
		<title level="j">Journal of General Virology</title>
		<title level="j" type="abbrev">Journal of General Virology</title>
		<idno type="ISSN">0022-1317</idno>
		<idno type="ISSNe">1465-2099</idno>
		<imprint>
			<biblScope unit="volume">87</biblScope>
			<biblScope unit="issue">12</biblScope>
			<biblScope unit="page" from="3753" to="3761" />
			<date type="published" when="2006-12-01" />
			<publisher>Microbiology Society</publisher>
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b8">
	<analytic>
		<title level="a" type="main">Scullcap: a Herbal Enigma</title>
		<author>
			<persName xmlns="http://www.tei-c.org/ns/1.0"><forename type="first">S</forename><surname>Foster</surname></persName>
		</author>
	</analytic>
	<monogr>
		<title level="j">Business Herbs</title>
		<imprint>
			<biblScope unit="page" from="14" to="16" />
			<date type="published" when="1996" />
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b9">
	<analytic>
		<title level="a" type="main">The sequential development of the brain lesions of scrapie in three strains of mice</title>
		<author>
			<persName xmlns="http://www.tei-c.org/ns/1.0"><forename type="first">H</forename><surname>Fraser</surname></persName>
		</author>
		<author>
			<persName xmlns="http://www.tei-c.org/ns/1.0"><forename type="first">A</forename><forename type="middle">G</forename><surname>Dickinson</surname></persName>
		</author>
		<idno type="DOI">10.1016/0021-9975(68)90006-6</idno>
		<idno type="PMID">4970192</idno>
		<idno type="PII">0021-9975(68)90006-6</idno>
		<idno type="ark">ark:/67375/6H6-JC8ML0KK-D</idno>
		<idno type="istexId">3FB0BECF6EC8CC5643BCAA3E640D7D7AD023E6DC</idno>
	</analytic>
	<monogr>
		<title level="j">Journal of Comparative Pathology</title>
		<title level="j" type="abbrev">Journal of Comparative Pathology</title>
		<idno type="ISSN">0021-9975</idno>
		<imprint>
			<biblScope unit="volume">78</biblScope>
			<biblScope unit="issue">3</biblScope>
			<biblScope unit="page" from="301" to="311" />
			<date type="published" when="1968-07" />
			<publisher>Elsevier BV</publisher>
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b10">
	<analytic>
		<title level="a" type="main">A traditional medicinal herb Paeonia suffruticosa and its active constituent 1,2,3,4,6-penta-Ogalloyl-beta-d-glucopyranose have potent anti-aggregation effects on Alzheimer&apos;s amyloid beta proteins in vitro and in vivo</title>
		<author>
			<persName xmlns="http://www.tei-c.org/ns/1.0"><forename type="first">H</forename><surname>Fujiwara</surname></persName>
		</author>
		<author>
			<persName xmlns="http://www.tei-c.org/ns/1.0"><forename type="first">M</forename><surname>Tabuchi</surname></persName>
		</author>
		<author>
			<persName xmlns="http://www.tei-c.org/ns/1.0"><forename type="first">T</forename><surname>Yamaguchi</surname></persName>
		</author>
		<author>
			<persName xmlns="http://www.tei-c.org/ns/1.0"><forename type="first">K</forename><surname>Iwasaki</surname></persName>
		</author>
		<author>
			<persName xmlns="http://www.tei-c.org/ns/1.0"><forename type="first">K</forename><surname>Furukawa</surname></persName>
		</author>
		<author>
			<persName xmlns="http://www.tei-c.org/ns/1.0"><forename type="first">K</forename><surname>Sekiguchi</surname></persName>
		</author>
		<author>
			<persName xmlns="http://www.tei-c.org/ns/1.0"><forename type="first">Y</forename><surname>Ikarashi</surname></persName>
		</author>
		<author>
			<persName xmlns="http://www.tei-c.org/ns/1.0"><forename type="first">Y</forename><surname>Kudo</surname></persName>
		</author>
		<author>
			<persName xmlns="http://www.tei-c.org/ns/1.0"><forename type="first">M</forename><surname>Higuchi</surname></persName>
		</author>
		<author>
			<persName xmlns="http://www.tei-c.org/ns/1.0"><forename type="first">T</forename><forename type="middle">C</forename><surname>Saido</surname></persName>
		</author>
		<author>
			<persName xmlns="http://www.tei-c.org/ns/1.0"><forename type="first">S</forename><surname>Maeda</surname></persName>
		</author>
		<author>
			<persName xmlns="http://www.tei-c.org/ns/1.0"><forename type="first">A</forename><surname>Takashima</surname></persName>
		</author>
		<author>
			<persName xmlns="http://www.tei-c.org/ns/1.0"><forename type="first">M</forename><surname>Hara</surname></persName>
		</author>
		<author>
			<persName xmlns="http://www.tei-c.org/ns/1.0"><forename type="first">N</forename><surname>Yaegashi</surname></persName>
		</author>
		<author>
			<persName xmlns="http://www.tei-c.org/ns/1.0"><forename type="first">Y</forename><surname>Kase</surname></persName>
		</author>
		<author>
			<persName xmlns="http://www.tei-c.org/ns/1.0"><forename type="first">H</forename><surname>Arai</surname></persName>
		</author>
	</analytic>
	<monogr>
		<title level="j">J. Neurochem</title>
		<imprint>
			<biblScope unit="volume">109</biblScope>
			<biblScope unit="page" from="1648" to="1657" />
			<date type="published" when="2009" />
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b11">
	<analytic>
		<title level="a" type="main">From High-Throughput Cell Culture Screening to Mouse Model: Identification of New Inhibitor Classes against Prion Disease</title>
		<author>
			<persName xmlns="http://www.tei-c.org/ns/1.0"><forename type="first">Markus</forename><surname>Geissen</surname></persName>
		</author>
		<author>
			<persName xmlns="http://www.tei-c.org/ns/1.0"><forename type="first">Fabienne</forename><surname>Leidel</surname></persName>
		</author>
		<author>
			<persName xmlns="http://www.tei-c.org/ns/1.0"><forename type="first">Martin</forename><surname>Eiden</surname></persName>
		</author>
		<author>
			<persName xmlns="http://www.tei-c.org/ns/1.0"><forename type="first">Thomas</forename><surname>Hirschberger</surname></persName>
		</author>
		<author>
			<persName xmlns="http://www.tei-c.org/ns/1.0"><forename type="first">Christine</forename><surname>Fast</surname></persName>
		</author>
		<author>
			<persName xmlns="http://www.tei-c.org/ns/1.0"><forename type="first">Uwe</forename><surname>Bertsch</surname></persName>
		</author>
		<author>
			<persName xmlns="http://www.tei-c.org/ns/1.0"><forename type="first">Paul</forename><surname>Tavan</surname></persName>
		</author>
		<author>
			<persName xmlns="http://www.tei-c.org/ns/1.0"><forename type="first">Armin</forename><surname>Giese</surname></persName>
		</author>
		<author>
			<persName xmlns="http://www.tei-c.org/ns/1.0"><forename type="first">Hans</forename><surname>Kretzschmar</surname></persName>
		</author>
		<author>
			<persName xmlns="http://www.tei-c.org/ns/1.0"><forename type="first">Hermann</forename><forename type="middle">M</forename><surname>Schatzl</surname></persName>
		</author>
		<author>
			<persName xmlns="http://www.tei-c.org/ns/1.0"><forename type="first">Martin</forename><forename type="middle">H</forename><surname>Groschup</surname></persName>
		</author>
		<idno type="DOI">10.1002/cmdc.201100119</idno>
		<idno type="PMID">21755599</idno>
		<idno type="ark">ark:/67375/WNG-3WVSWGL4-X</idno>
		<idno type="istexId">ED261BA330D9F71CE110ACDDA075D22B74B63D26</idno>
	</analytic>
	<monogr>
		<title level="j">ChemMedChem</title>
		<title level="j" type="abbrev">ChemMedChem</title>
		<idno type="ISSN">1860-7179</idno>
		<imprint>
			<biblScope unit="volume">6</biblScope>
			<biblScope unit="issue">10</biblScope>
			<biblScope unit="page" from="1928" to="1937" />
			<date type="published" when="2011-07-13" />
			<publisher>Wiley</publisher>
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b12">
	<analytic>
		<title level="a" type="main">Strain Typing of German Transmissible Spongiform Encephalopathies Field Cases in Small Ruminants by Biochemical Methods</title>
		<author>
			<persName xmlns="http://www.tei-c.org/ns/1.0"><forename type="first">A</forename><surname>Gretzschel</surname></persName>
		</author>
		<author>
			<persName xmlns="http://www.tei-c.org/ns/1.0"><forename type="first">A</forename><surname>Buschmann</surname></persName>
		</author>
		<author>
			<persName xmlns="http://www.tei-c.org/ns/1.0"><forename type="first">M</forename><surname>Eiden</surname></persName>
		</author>
		<author>
			<persName xmlns="http://www.tei-c.org/ns/1.0"><forename type="first">U</forename><surname>Ziegler</surname></persName>
		</author>
		<author>
			<persName xmlns="http://www.tei-c.org/ns/1.0"><forename type="first">G</forename><surname>Luhken</surname></persName>
		</author>
		<author>
			<persName xmlns="http://www.tei-c.org/ns/1.0"><forename type="first">G</forename><surname>Erhardt</surname></persName>
		</author>
		<author>
			<persName xmlns="http://www.tei-c.org/ns/1.0"><forename type="first">M</forename><forename type="middle">H</forename><surname>Groschup</surname></persName>
		</author>
		<idno type="DOI">10.1111/j.1439-0450.2005.00827.x</idno>
		<idno type="PMID">15752263</idno>
		<idno type="ark">ark:/67375/WNG-J69NBCRF-J</idno>
		<idno type="istexId">E642B447F466CAAFFFB53DAAE70CEABF4E1F76EE</idno>
	</analytic>
	<monogr>
		<title level="j">Journal of Veterinary Medicine Series B</title>
		<title level="j" type="abbrev">J Vet Med Series B</title>
		<idno type="ISSN">0931-1793</idno>
		<idno type="ISSNe">1439-0450</idno>
		<imprint>
			<biblScope unit="volume">52</biblScope>
			<biblScope unit="issue">2</biblScope>
			<biblScope unit="page" from="55" to="63" />
			<date type="published" when="2005-03" />
			<publisher>Wiley</publisher>
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b13">
	<analytic>
		<title level="a" type="main">Antigenic features of prion proteins of sheep and of other mammalian species</title>
		<author>
			<persName xmlns="http://www.tei-c.org/ns/1.0"><forename type="first">Martin</forename><forename type="middle">H</forename><surname>Groschup</surname></persName>
		</author>
		<author>
			<persName xmlns="http://www.tei-c.org/ns/1.0"><forename type="first">Silke</forename><surname>Harmeyer</surname></persName>
		</author>
		<author>
			<persName xmlns="http://www.tei-c.org/ns/1.0"><forename type="first">Eberhard</forename><surname>Pfaff</surname></persName>
		</author>
		<idno type="DOI">10.1016/s0022-1759(97)00121-x</idno>
		<idno type="PMID">9328590</idno>
		<idno type="PII">S0022-1759(97)00121-X</idno>
		<idno type="ark">ark:/67375/6H6-DL4L3DP7-F</idno>
		<idno type="istexId">5CF934B4966C1787838DB3DAE51267F166BA455C</idno>
	</analytic>
	<monogr>
		<title level="j">Journal of Immunological Methods</title>
		<title level="j" type="abbrev">Journal of Immunological Methods</title>
		<idno type="ISSN">0022-1759</idno>
		<imprint>
			<biblScope unit="volume">207</biblScope>
			<biblScope unit="issue">1</biblScope>
			<biblScope unit="page" from="89" to="101" />
			<date type="published" when="1997-08" />
			<publisher>Elsevier BV</publisher>
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b14">
	<analytic>
		<title level="a" type="main">The major species specific epitope in prion proteins of ruminants</title>
		<author>
			<persName xmlns="http://www.tei-c.org/ns/1.0"><forename type="first">M</forename><forename type="middle">H</forename><surname>Groschup</surname></persName>
		</author>
		<author>
			<persName xmlns="http://www.tei-c.org/ns/1.0"><forename type="first">J</forename><surname>Langeveld</surname></persName>
		</author>
		<author>
			<persName xmlns="http://www.tei-c.org/ns/1.0"><forename type="first">E</forename><surname>Pfaff</surname></persName>
		</author>
		<idno type="DOI">10.1007/bf01321071</idno>
		<idno type="PMID">7518226</idno>
		<idno type="ark">ark:/67375/1BB-WH14RHGT-9</idno>
		<idno type="istexId">630A9AA87F8BB65520F1D61DFFD3AA79E001C39C</idno>
	</analytic>
	<monogr>
		<title level="j">Archives of Virology</title>
		<title level="j" type="abbrev">Archives of Virology</title>
		<idno type="ISSN">0304-8608</idno>
		<idno type="ISSNe">1432-8798</idno>
		<imprint>
			<biblScope unit="volume">136</biblScope>
			<biblScope unit="issue">3-4</biblScope>
			<biblScope unit="page" from="423" to="431" />
			<date type="published" when="1994-09" />
			<publisher>Springer Nature</publisher>
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b15">
	<analytic>
		<title level="a" type="main">A Comparative Study of Immunohistochemical Methods for Detecting Abnormal Prion Protein with Monoclonal and Polyclonal Antibodies</title>
		<author>
			<persName xmlns="http://www.tei-c.org/ns/1.0"><forename type="first">M</forename><surname>Hardt</surname></persName>
		</author>
		<author>
			<persName xmlns="http://www.tei-c.org/ns/1.0"><forename type="first">T</forename><surname>Baron</surname></persName>
		</author>
		<author>
			<persName xmlns="http://www.tei-c.org/ns/1.0"><forename type="first">M</forename><forename type="middle">H</forename><surname>Groschup</surname></persName>
		</author>
		<idno type="DOI">10.1053/jcpa.1999.0343</idno>
		<idno type="PMID">10627390</idno>
		<idno type="PII">S0021-9975(99)90343-2</idno>
		<idno type="ark">ark:/67375/6H6-B10KJJF2-4</idno>
		<idno type="istexId">D0964B2C473EF0636ECD3FB765F71F8AB240E033</idno>
	</analytic>
	<monogr>
		<title level="j">Journal of Comparative Pathology</title>
		<title level="j" type="abbrev">Journal of Comparative Pathology</title>
		<idno type="ISSN">0021-9975</idno>
		<imprint>
			<biblScope unit="volume">122</biblScope>
			<biblScope unit="issue">1</biblScope>
			<biblScope unit="page" from="43" to="53" />
			<date type="published" when="2000-01" />
			<publisher>Elsevier BV</publisher>
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b16">
	<analytic>
		<title level="a" type="main">Lithium induces clearance of protease resistant prion protein in prion-infected cells by induction of autophagy</title>
		<author>
			<persName xmlns="http://www.tei-c.org/ns/1.0"><forename type="first">Andreas</forename><surname>Heiseke</surname></persName>
		</author>
		<author>
			<persName xmlns="http://www.tei-c.org/ns/1.0"><forename type="first">Yasmine</forename><surname>Aguib</surname></persName>
		</author>
		<author>
			<persName xmlns="http://www.tei-c.org/ns/1.0"><forename type="first">Constanze</forename><surname>Riemer</surname></persName>
		</author>
		<author>
			<persName xmlns="http://www.tei-c.org/ns/1.0"><forename type="first">Michael</forename><surname>Baier</surname></persName>
		</author>
		<author>
			<persName xmlns="http://www.tei-c.org/ns/1.0"><forename type="first">Hermann</forename><forename type="middle">M</forename><surname>SchÃ¤tzl</surname></persName>
		</author>
		<idno type="DOI">10.1111/j.1471-4159.2009.05906.x</idno>
		<idno type="PMID">19183256</idno>
	</analytic>
	<monogr>
		<title level="j">Journal of Neurochemistry</title>
		<idno type="ISSN">0022-3042</idno>
		<idno type="ISSNe">1471-4159</idno>
		<imprint>
			<biblScope unit="volume">109</biblScope>
			<biblScope unit="issue">1</biblScope>
			<biblScope unit="page" from="25" to="34" />
			<date type="published" when="2009-04" />
			<publisher>Wiley</publisher>
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b17">
	<analytic>
		<title level="a" type="main">Interactions between heterologous forms of prion protein: Binding, inhibition of conversion, and species barriers</title>
		<author>
			<persName xmlns="http://www.tei-c.org/ns/1.0"><forename type="first">M</forename><surname>Horiuchi</surname></persName>
		</author>
		<author>
			<persName xmlns="http://www.tei-c.org/ns/1.0"><forename type="first">S</forename><forename type="middle">A</forename><surname>Priola</surname></persName>
		</author>
		<author>
			<persName xmlns="http://www.tei-c.org/ns/1.0"><forename type="first">J</forename><surname>Chabry</surname></persName>
		</author>
		<author>
			<persName xmlns="http://www.tei-c.org/ns/1.0"><forename type="first">B</forename><surname>Caughey</surname></persName>
		</author>
		<idno type="DOI">10.1073/pnas.110523897</idno>
		<idno type="PMID">10811921</idno>
		<idno type="PMCID">PMC18520</idno>
		<ptr type="open-access" target="http://www.pnas.org/content/97/11/5836.full.pdf" />
	</analytic>
	<monogr>
		<title level="j">Proceedings of the National Academy of Sciences</title>
		<title level="j" type="abbrev">Proceedings of the National Academy of Sciences</title>
		<idno type="ISSN">0027-8424</idno>
		<idno type="ISSNe">1091-6490</idno>
		<imprint>
			<biblScope unit="volume">97</biblScope>
			<biblScope unit="issue">11</biblScope>
			<biblScope unit="page" from="5836" to="5841" />
			<date type="published" when="2000-05-16" />
			<publisher>Proceedings of the National Academy of Sciences</publisher>
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b18">
	<analytic>
		<title level="a" type="main">Seeding âone-dimensional crystallizationâ of amyloid: A pathogenic mechanism in Alzheimer&apos;s disease and scrapie?</title>
		<author>
			<persName xmlns="http://www.tei-c.org/ns/1.0"><forename type="first">Joseph</forename><forename type="middle">T</forename><surname>Jarrett</surname></persName>
		</author>
		<author>
			<persName xmlns="http://www.tei-c.org/ns/1.0"><forename type="first">Peter</forename><forename type="middle">T</forename><surname>Lansbury</surname></persName>
		</author>
		<idno type="DOI">10.1016/0092-8674(93)90635-4</idno>
		<idno type="PMID">8513491</idno>
		<idno type="PII">0092-8674(93)90635-4</idno>
		<idno type="ark">ark:/67375/6H6-8X3T1DV3-H</idno>
		<idno type="istexId">299D7D253238C0E282070C7B91D9F5B53C76A092</idno>
	</analytic>
	<monogr>
		<title level="j">Cell</title>
		<title level="j" type="abbrev">Cell</title>
		<idno type="ISSN">0092-8674</idno>
		<imprint>
			<biblScope unit="volume">73</biblScope>
			<biblScope unit="issue">6</biblScope>
			<biblScope unit="page" from="1055" to="1058" />
			<date type="published" when="1993-06" />
			<publisher>Elsevier BV</publisher>
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b19">
	<analytic>
		<title level="a" type="main">Baicalein inhibits oxidative stress-induced cellular damage via antioxidant effects</title>
		<author>
			<persName xmlns="http://www.tei-c.org/ns/1.0"><forename type="first">Kyoung</forename><forename type="middle">Ah</forename><surname>Kang</surname></persName>
		</author>
		<author>
			<persName xmlns="http://www.tei-c.org/ns/1.0"><forename type="first">Rui</forename><surname>Zhang</surname></persName>
		</author>
		<author>
			<persName xmlns="http://www.tei-c.org/ns/1.0"><forename type="first">Mei</forename><forename type="middle">Jing</forename><surname>Piao</surname></persName>
		</author>
		<author>
			<persName xmlns="http://www.tei-c.org/ns/1.0"><forename type="first">Sungwook</forename><surname>Chae</surname></persName>
		</author>
		<author>
			<persName xmlns="http://www.tei-c.org/ns/1.0"><forename type="first">Hee</forename><forename type="middle">Sun</forename><surname>Kim</surname></persName>
		</author>
		<author>
			<persName xmlns="http://www.tei-c.org/ns/1.0"><forename type="first">Jun</forename><forename type="middle">Ho</forename><surname>Park</surname></persName>
		</author>
		<author>
			<persName xmlns="http://www.tei-c.org/ns/1.0"><forename type="first">Kwang</forename><forename type="middle">Sun</forename><surname>Jung</surname></persName>
		</author>
		<author>
			<persName xmlns="http://www.tei-c.org/ns/1.0"><forename type="first">Jin</forename><forename type="middle">Won</forename><surname>Hyun</surname></persName>
		</author>
		<idno type="DOI">10.1177/0748233711413799</idno>
		<idno type="PMID">21957089</idno>
	</analytic>
	<monogr>
		<title level="j">Toxicology and Industrial Health</title>
		<title level="j" type="abbrev">Toxicol Ind Health</title>
		<idno type="ISSN">0748-2337</idno>
		<idno type="ISSNe">1477-0393</idno>
		<imprint>
			<biblScope unit="volume">28</biblScope>
			<biblScope unit="issue">5</biblScope>
			<biblScope unit="page" from="412" to="421" />
			<date type="published" when="2011-09-28" />
			<publisher>SAGE Publications</publisher>
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b20">
	<analytic>
		<title level="a" type="main">Orally Administered Amyloidophilic Compound Is Effective in Prolonging the Incubation Periods of Animals Cerebrally Infected with Prion Diseases in a Prion Strain-Dependent Manner</title>
		<author>
			<persName xmlns="http://www.tei-c.org/ns/1.0"><forename type="first">Y</forename><surname>Kawasaki</surname></persName>
		</author>
		<author>
			<persName xmlns="http://www.tei-c.org/ns/1.0"><forename type="first">K</forename><surname>Kawagoe</surname></persName>
		</author>
		<author>
			<persName xmlns="http://www.tei-c.org/ns/1.0"><forename type="first">C-J</forename><surname>Chen</surname></persName>
		</author>
		<author>
			<persName xmlns="http://www.tei-c.org/ns/1.0"><forename type="first">K</forename><surname>Teruya</surname></persName>
		</author>
		<author>
			<persName xmlns="http://www.tei-c.org/ns/1.0"><forename type="first">Y</forename><surname>Sakasegawa</surname></persName>
		</author>
		<author>
			<persName xmlns="http://www.tei-c.org/ns/1.0"><forename type="first">K</forename><surname>Doh-Ura</surname></persName>
		</author>
		<idno type="DOI">10.1128/jvi.01563-07</idno>
		<idno type="PMID">17881452</idno>
		<idno type="PMCID">PMC2169081</idno>
		<ptr type="open-access" target="https://jvi.asm.org/content/81/23/12889.full.pdf" />
	</analytic>
	<monogr>
		<title level="j">Journal of Virology</title>
		<title level="j" type="abbrev">Journal of Virology</title>
		<idno type="ISSN">0022-538X</idno>
		<imprint>
			<biblScope unit="volume">81</biblScope>
			<biblScope unit="issue">23</biblScope>
			<biblScope unit="page" from="12889" to="12898" />
			<date type="published" when="2007-09-19" />
			<publisher>American Society for Microbiology</publisher>
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b21">
	<analytic>
		<title level="a" type="main">New Inhibitors of Scrapie-Associated Prion Protein Formation in a Library of 2,000 Drugs and Natural Products</title>
		<author>
			<persName xmlns="http://www.tei-c.org/ns/1.0"><forename type="first">D</forename><forename type="middle">A</forename><surname>Kocisko</surname></persName>
		</author>
		<author>
			<persName xmlns="http://www.tei-c.org/ns/1.0"><forename type="first">G</forename><forename type="middle">S</forename><surname>Baron</surname></persName>
		</author>
		<author>
			<persName xmlns="http://www.tei-c.org/ns/1.0"><forename type="first">R</forename><surname>Rubenstein</surname></persName>
		</author>
		<author>
			<persName xmlns="http://www.tei-c.org/ns/1.0"><forename type="first">J</forename><surname>Chen</surname></persName>
		</author>
		<author>
			<persName xmlns="http://www.tei-c.org/ns/1.0"><forename type="first">S</forename><surname>Kuizon</surname></persName>
		</author>
		<author>
			<persName xmlns="http://www.tei-c.org/ns/1.0"><forename type="first">B</forename><surname>Caughey</surname></persName>
		</author>
		<idno type="DOI">10.1128/jvi.78.6.3202.2004</idno>
		<ptr type="open-access" target="https://jvi.asm.org/content/78/6/3202.full.pdf" />
	</analytic>
	<monogr>
		<title level="j">Journal of Virology</title>
		<title level="j" type="abbrev">Journal of Virology</title>
		<idno type="ISSN">0022-538X</idno>
		<imprint>
			<biblScope unit="volume">78</biblScope>
			<biblScope unit="issue">6</biblScope>
			<biblScope unit="page" from="3202" to="3202" />
			<date type="published" when="2004-02-27" />
			<publisher>American Society for Microbiology</publisher>
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b22">
	<analytic>
		<title level="a" type="main">Evaluation of new cell culture inhibitors of protease-resistant prion protein against scrapie infection in mice</title>
		<author>
			<persName xmlns="http://www.tei-c.org/ns/1.0"><forename type="first">D</forename><forename type="middle">A</forename><surname>Kocisko</surname></persName>
		</author>
		<author>
			<persName xmlns="http://www.tei-c.org/ns/1.0"><forename type="first">J</forename><forename type="middle">D</forename><surname>Morrey</surname></persName>
		</author>
		<author>
			<persName xmlns="http://www.tei-c.org/ns/1.0"><forename type="first">R</forename><forename type="middle">E</forename><surname>Race</surname></persName>
		</author>
		<author>
			<persName xmlns="http://www.tei-c.org/ns/1.0"><forename type="first">J</forename><surname>Chen</surname></persName>
		</author>
		<author>
			<persName xmlns="http://www.tei-c.org/ns/1.0"><forename type="first">B</forename><surname>Caughey</surname></persName>
		</author>
		<idno type="DOI">10.1099/vir.0.80082-0</idno>
		<idno type="PMID">15269390</idno>
	</analytic>
	<monogr>
		<title level="j">Journal of General Virology</title>
		<title level="j" type="abbrev">Journal of General Virology</title>
		<idno type="ISSN">0022-1317</idno>
		<idno type="ISSNe">1465-2099</idno>
		<imprint>
			<biblScope unit="volume">85</biblScope>
			<biblScope unit="issue">8</biblScope>
			<biblScope unit="page" from="2479" to="2483" />
			<date type="published" when="2004-08-01" />
			<publisher>Microbiology Society</publisher>
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b23">
	<analytic>
		<title level="a" type="main">Amino acid sequence and prion strain specific effects on the in vitro and in vivo convertibility of ovine/murine and bovine/murine prion protein chimeras</title>
		<author>
			<persName xmlns="http://www.tei-c.org/ns/1.0"><forename type="first">Leila</forename><surname>Kupfer</surname></persName>
		</author>
		<author>
			<persName xmlns="http://www.tei-c.org/ns/1.0"><forename type="first">Martin</forename><surname>Eiden</surname></persName>
		</author>
		<author>
			<persName xmlns="http://www.tei-c.org/ns/1.0"><forename type="first">Anne</forename><surname>Buschmann</surname></persName>
		</author>
		<author>
			<persName xmlns="http://www.tei-c.org/ns/1.0"><forename type="first">Martin</forename><forename type="middle">H</forename><surname>Groschup</surname></persName>
		</author>
		<idno type="DOI">10.1016/j.bbadis.2006.10.009</idno>
		<idno type="PMID">17145171</idno>
		<ptr type="open-access" target="https://hal.archives-ouvertes.fr/hal-00501526/file/PEER_stage2_10.1016%252Fj.bbadis.2006.10.009.pdf" />
	</analytic>
	<monogr>
		<title level="j">Biochimica et Biophysica Acta (BBA) - Molecular Basis of Disease</title>
		<title level="j" type="abbrev">Biochimica et Biophysica Acta (BBA) - Molecular Basis of Disease</title>
		<idno type="ISSN">0925-4439</idno>
		<imprint>
			<biblScope unit="volume">1772</biblScope>
			<biblScope unit="issue">6</biblScope>
			<biblScope unit="page" from="704" to="713" />
			<date type="published" when="2007-06" />
			<publisher>Elsevier BV</publisher>
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b24">
	<analytic>
		<title level="a" type="main">Diphenylpyrazole-Derived Compounds Increase Survival Time of Mice after Prion Infection</title>
		<author>
			<persName xmlns="http://www.tei-c.org/ns/1.0"><forename type="first">Fabienne</forename><surname>Leidel</surname></persName>
		</author>
		<author>
			<persName xmlns="http://www.tei-c.org/ns/1.0"><forename type="first">Martin</forename><surname>Eiden</surname></persName>
		</author>
		<author>
			<persName xmlns="http://www.tei-c.org/ns/1.0"><forename type="first">Markus</forename><surname>Geissen</surname></persName>
		</author>
		<author>
			<persName xmlns="http://www.tei-c.org/ns/1.0"><forename type="first">Hans</forename><forename type="middle">A</forename><surname>Kretzschmar</surname></persName>
		</author>
		<author>
			<persName xmlns="http://www.tei-c.org/ns/1.0"><forename type="first">Armin</forename><surname>Giese</surname></persName>
		</author>
		<author>
			<persName xmlns="http://www.tei-c.org/ns/1.0"><forename type="first">Thomas</forename><surname>Hirschberger</surname></persName>
		</author>
		<author>
			<persName xmlns="http://www.tei-c.org/ns/1.0"><forename type="first">Paul</forename><surname>Tavan</surname></persName>
		</author>
		<author>
			<persName xmlns="http://www.tei-c.org/ns/1.0"><forename type="first">Hermann</forename><forename type="middle">M</forename><surname>SchÃ¤tzl</surname></persName>
		</author>
		<author>
			<persName xmlns="http://www.tei-c.org/ns/1.0"><forename type="first">Martin</forename><forename type="middle">H</forename><surname>Groschup</surname></persName>
		</author>
		<idno type="DOI">10.1128/aac.00151-11</idno>
		<idno type="PMID">21746938</idno>
		<idno type="PMCID">PMC3186986</idno>
		<ptr type="open-access" target="https://aac.asm.org/content/aac/55/10/4774.full.pdf" />
	</analytic>
	<monogr>
		<title level="j">Antimicrobial Agents and Chemotherapy</title>
		<title level="j" type="abbrev">Antimicrob. Agents Chemother.</title>
		<idno type="ISSN">0066-4804</idno>
		<idno type="ISSNe">1098-6596</idno>
		<imprint>
			<biblScope unit="volume">55</biblScope>
			<biblScope unit="issue">10</biblScope>
			<biblScope unit="page" from="4774" to="4781" />
			<date type="published" when="2011-07-11" />
			<publisher>American Society for Microbiology</publisher>
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b25">
	<analytic>
		<title level="a" type="main">Baicalin attenuates oxygen-glucose deprivation-induced injury by inhibiting oxidative stress-mediated 5-lipoxygenase activation in PC12 cells</title>
		<author>
			<persName xmlns="http://www.tei-c.org/ns/1.0"><forename type="first">Cheng-Tan</forename><surname>Li</surname></persName>
		</author>
		<author>
			<persName xmlns="http://www.tei-c.org/ns/1.0"><forename type="first">Wei-Ping</forename><surname>Zhang</surname></persName>
		</author>
		<author>
			<persName xmlns="http://www.tei-c.org/ns/1.0"><forename type="first">San-Hua</forename><surname>Fang</surname></persName>
		</author>
		<author>
			<persName xmlns="http://www.tei-c.org/ns/1.0"><forename type="first">Yun-Bi</forename><surname>Lu</surname></persName>
		</author>
		<author>
			<persName xmlns="http://www.tei-c.org/ns/1.0"><forename type="first">Li-Hui</forename><surname>Zhang</surname></persName>
		</author>
		<author>
			<persName xmlns="http://www.tei-c.org/ns/1.0"><forename type="first">Ling-Ling</forename><surname>Qi</surname></persName>
		</author>
		<author>
			<persName xmlns="http://www.tei-c.org/ns/1.0"><forename type="first">Xue-Qin</forename><surname>Huang</surname></persName>
		</author>
		<author>
			<persName xmlns="http://www.tei-c.org/ns/1.0"><forename type="first">Xiao-Jia</forename><surname>Huang</surname></persName>
		</author>
		<author>
			<persName xmlns="http://www.tei-c.org/ns/1.0"><forename type="first">Er-Qing</forename><surname>Wei</surname></persName>
		</author>
		<idno type="DOI">10.1038/aps.2009.196</idno>
		<idno type="PMID">20139896</idno>
		<idno type="PMCID">PMC4002841</idno>
		<ptr type="open-access" target="https://www.nature.com/articles/aps2009196.pdf" />
	</analytic>
	<monogr>
		<title level="j">Acta Pharmacologica Sinica</title>
		<title level="j" type="abbrev">Acta Pharmacol Sin</title>
		<idno type="ISSN">1671-4083</idno>
		<idno type="ISSNe">1745-7254</idno>
		<imprint>
			<biblScope unit="volume">31</biblScope>
			<biblScope unit="issue">2</biblScope>
			<biblScope unit="page" from="137" to="144" />
			<date type="published" when="2010-02" />
			<publisher>Springer Nature</publisher>
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b26">
	<analytic>
		<title level="a" type="main">Grape seed polyphenolic extract specifically decreases AÎ² â 56 in the brains of Tg2576 mice</title>
		<author>
			<persName xmlns="http://www.tei-c.org/ns/1.0"><forename type="first">Peng</forename><surname>Liu</surname></persName>
		</author>
		<author>
			<persName xmlns="http://www.tei-c.org/ns/1.0"><forename type="first">Linda</forename><forename type="middle">A</forename><surname>Kotilinek</surname></persName>
		</author>
		<author>
			<persName xmlns="http://www.tei-c.org/ns/1.0"><forename type="first">Lisa</forename><forename type="middle">J</forename><surname>Kemper</surname></persName>
		</author>
		<author>
			<persName xmlns="http://www.tei-c.org/ns/1.0"><forename type="first">Jun</forename><surname>Wang</surname></persName>
		</author>
		<author>
			<persName xmlns="http://www.tei-c.org/ns/1.0"><forename type="first">Kathleen</forename><forename type="middle">R</forename><surname>Zahs</surname></persName>
		</author>
		<author>
			<persName xmlns="http://www.tei-c.org/ns/1.0"><forename type="first">Karen</forename><forename type="middle">H</forename><surname>Ashe</surname></persName>
		</author>
		<author>
			<persName xmlns="http://www.tei-c.org/ns/1.0"><forename type="first">Giulio</forename><forename type="middle">M</forename><surname>Pasinetti</surname></persName>
		</author>
		<idno type="DOI">10.1016/j.jalz.2010.05.1792</idno>
	</analytic>
	<monogr>
		<title level="j">Alzheimer&apos;s &amp; Dementia</title>
		<title level="j" type="abbrev">Alzheimer&apos;s &amp; Dementia</title>
		<idno type="ISSN">1552-5260</idno>
		<imprint>
			<biblScope unit="volume">6</biblScope>
			<biblScope unit="issue">4</biblScope>
			<biblScope unit="page">S537</biblScope>
			<date type="published" when="2010-07" />
			<publisher>Elsevier BV</publisher>
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b27">
	<analytic>
		<title level="a" type="main">Baicalein Inhibits Formation of Î±-Synuclein Oligomers within Living Cells and Prevents AÎ² Peptide Fibrillation and Oligomerisation</title>
		<author>
			<persName xmlns="http://www.tei-c.org/ns/1.0"><forename type="first">Jia-Hong</forename><surname>Lu</surname></persName>
		</author>
		<author>
			<persName xmlns="http://www.tei-c.org/ns/1.0"><forename type="first">Mustafa</forename><forename type="middle">Taleb</forename><surname>Ardah</surname></persName>
		</author>
		<author>
			<persName xmlns="http://www.tei-c.org/ns/1.0"><forename type="first">Siva</forename><forename type="middle">Sundara Kumar</forename><surname>Durairajan</surname></persName>
		</author>
		<author>
			<persName xmlns="http://www.tei-c.org/ns/1.0"><forename type="first">Liang-Feng</forename><surname>Liu</surname></persName>
		</author>
		<author>
			<persName xmlns="http://www.tei-c.org/ns/1.0"><forename type="first">Li-Xia</forename><surname>Xie</surname></persName>
		</author>
		<author>
			<persName xmlns="http://www.tei-c.org/ns/1.0"><forename type="first">Wang-Fun David</forename><surname>Fong</surname></persName>
		</author>
		<author>
			<persName xmlns="http://www.tei-c.org/ns/1.0"><forename type="first">Mohamed</forename><forename type="middle">Y</forename><surname>Hasan</surname></persName>
		</author>
		<author>
			<persName xmlns="http://www.tei-c.org/ns/1.0"><forename type="first">Jian-Dong</forename><surname>Huang</surname></persName>
		</author>
		<author>
			<persName xmlns="http://www.tei-c.org/ns/1.0"><forename type="first">Omar</forename><forename type="middle">M A</forename><surname>El-Agnaf</surname></persName>
		</author>
		<author>
			<persName xmlns="http://www.tei-c.org/ns/1.0"><forename type="first">Min</forename><surname>Li</surname></persName>
		</author>
		<idno type="DOI">10.1002/cbic.201000604</idno>
		<idno type="PMID">21271629</idno>
		<idno type="ark">ark:/67375/WNG-0J6525Q6-G</idno>
		<idno type="istexId">8B7F6C640238942AA74CF26490C0A9EBAE06DC5B</idno>
	</analytic>
	<monogr>
		<title level="j">ChemBioChem</title>
		<title level="j" type="abbrev">ChemBioChem</title>
		<idno type="ISSN">1439-4227</idno>
		<imprint>
			<biblScope unit="volume">12</biblScope>
			<biblScope unit="issue">4</biblScope>
			<biblScope unit="page" from="615" to="624" />
			<date type="published" when="2011-01-26" />
			<publisher>Wiley</publisher>
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b28">
	<analytic>
		<title level="a" type="main">Amphotericin B Inhibits the Generation of the Scrapie Isoform of the Prion Protein in Infected Cultures</title>
		<author>
			<persName xmlns="http://www.tei-c.org/ns/1.0"><forename type="first">A</forename><surname>Mange</surname></persName>
		</author>
		<author>
			<persName xmlns="http://www.tei-c.org/ns/1.0"><forename type="first">N</forename><surname>Nishida</surname></persName>
		</author>
		<author>
			<persName xmlns="http://www.tei-c.org/ns/1.0"><forename type="first">O</forename><surname>Milhavet</surname></persName>
		</author>
		<author>
			<persName xmlns="http://www.tei-c.org/ns/1.0"><forename type="first">H</forename><forename type="middle">E M</forename><surname>Mcmahon</surname></persName>
		</author>
		<author>
			<persName xmlns="http://www.tei-c.org/ns/1.0"><forename type="first">D</forename><surname>Casanova</surname></persName>
		</author>
		<author>
			<persName xmlns="http://www.tei-c.org/ns/1.0"><forename type="first">S</forename><surname>Lehmann</surname></persName>
		</author>
		<idno type="DOI">10.1128/jvi.74.7.3135-3140.2000</idno>
		<idno type="PMID">10708429</idno>
		<idno type="PMCID">PMC111813</idno>
		<ptr type="open-access" target="https://jvi.asm.org/content/74/7/3135.full.pdf" />
	</analytic>
	<monogr>
		<title level="j">Journal of Virology</title>
		<title level="j" type="abbrev">Journal of Virology</title>
		<idno type="ISSN">0022-538X</idno>
		<imprint>
			<biblScope unit="volume">74</biblScope>
			<biblScope unit="issue">7</biblScope>
			<biblScope unit="page" from="3135" to="3140" />
			<date type="published" when="2000-04-01" />
			<publisher>American Society for Microbiology</publisher>
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b29">
	<analytic>
		<title level="a" type="main">Quinoline Derivatives Are Therapeutic Candidates for Transmissible Spongiform Encephalopathies</title>
		<author>
			<persName xmlns="http://www.tei-c.org/ns/1.0"><forename type="first">I</forename><surname>Murakami-Kubo</surname></persName>
		</author>
		<author>
			<persName xmlns="http://www.tei-c.org/ns/1.0"><forename type="first">K</forename><surname>Doh-Ura</surname></persName>
		</author>
		<author>
			<persName xmlns="http://www.tei-c.org/ns/1.0"><forename type="first">K</forename><surname>Ishikawa</surname></persName>
		</author>
		<author>
			<persName xmlns="http://www.tei-c.org/ns/1.0"><forename type="first">S</forename><surname>Kawatake</surname></persName>
		</author>
		<author>
			<persName xmlns="http://www.tei-c.org/ns/1.0"><forename type="first">K</forename><surname>Sasaki</surname></persName>
		</author>
		<author>
			<persName xmlns="http://www.tei-c.org/ns/1.0"><forename type="first">J-I</forename><surname>Kira</surname></persName>
		</author>
		<author>
			<persName xmlns="http://www.tei-c.org/ns/1.0"><forename type="first">S</forename><surname>Ohta</surname></persName>
		</author>
		<author>
			<persName xmlns="http://www.tei-c.org/ns/1.0"><forename type="first">T</forename><surname>Iwaki</surname></persName>
		</author>
		<idno type="DOI">10.1128/jvi.78.3.1281-1288.2004</idno>
		<idno type="PMID">14722283</idno>
		<idno type="PMCID">PMC327112</idno>
		<ptr type="open-access" target="https://jvi.asm.org/content/78/3/1281.full.pdf" />
	</analytic>
	<monogr>
		<title level="j">Journal of Virology</title>
		<title level="j" type="abbrev">Journal of Virology</title>
		<idno type="ISSN">0022-538X</idno>
		<imprint>
			<biblScope unit="volume">78</biblScope>
			<biblScope unit="issue">3</biblScope>
			<biblScope unit="page" from="1281" to="1288" />
			<date type="published" when="2004-01-13" />
			<publisher>American Society for Microbiology</publisher>
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b30">
	<analytic>
		<title level="a" type="main">Lentivector-mediated RNAi efficiently suppresses prion protein and prolongs survival of scrapie-infected mice</title>
		<author>
			<persName xmlns="http://www.tei-c.org/ns/1.0"><forename type="first">Alexander</forename><surname>Pfeifer</surname></persName>
		</author>
		<author>
			<persName xmlns="http://www.tei-c.org/ns/1.0"><forename type="first">Sabina</forename><surname>Eigenbrod</surname></persName>
		</author>
		<author>
			<persName xmlns="http://www.tei-c.org/ns/1.0"><forename type="first">Saba</forename><surname>Al-Khadra</surname></persName>
		</author>
		<author>
			<persName xmlns="http://www.tei-c.org/ns/1.0"><forename type="first">Andreas</forename><surname>Hofmann</surname></persName>
		</author>
		<author>
			<persName xmlns="http://www.tei-c.org/ns/1.0"><forename type="first">Gerda</forename><surname>Mitteregger</surname></persName>
		</author>
		<author>
			<persName xmlns="http://www.tei-c.org/ns/1.0"><forename type="first">Markus</forename><surname>Moser</surname></persName>
		</author>
		<author>
			<persName xmlns="http://www.tei-c.org/ns/1.0"><forename type="first">Uwe</forename><surname>Bertsch</surname></persName>
		</author>
		<author>
			<persName xmlns="http://www.tei-c.org/ns/1.0"><forename type="first">Hans</forename><surname>Kretzschmar</surname></persName>
		</author>
		<idno type="DOI">10.1172/jci29236</idno>
		<idno type="PMID">17143329</idno>
		<idno type="PMCID">PMC1679709</idno>
		<ptr type="open-access" target="http://www.jci.org/articles/view/29236/files/pdf" />
	</analytic>
	<monogr>
		<title level="j">Journal of Clinical Investigation</title>
		<title level="j" type="abbrev">J. Clin. Invest.</title>
		<idno type="ISSN">0021-9738</idno>
		<imprint>
			<biblScope unit="volume">116</biblScope>
			<biblScope unit="issue">12</biblScope>
			<biblScope unit="page" from="3204" to="3210" />
			<date type="published" when="2006-12-01" />
			<publisher>American Society for Clinical Investigation</publisher>
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b31">
	<analytic>
		<title level="a" type="main">Porphyrin and Phthalocyanine Antiscrapie Compounds</title>
		<author>
			<persName xmlns="http://www.tei-c.org/ns/1.0"><forename type="first">S</forename><forename type="middle">A</forename><surname>Priola</surname></persName>
		</author>
		<author>
			<persName xmlns="http://www.tei-c.org/ns/1.0"><forename type="first">A</forename><surname>Raines</surname></persName>
		</author>
		<author>
			<persName xmlns="http://www.tei-c.org/ns/1.0"><forename type="first">W</forename><forename type="middle">S</forename><surname>Caughey</surname></persName>
		</author>
		<idno type="DOI">10.1126/science.287.5457.1503</idno>
		<idno type="PMID">10688802</idno>
		<ptr type="open-access" target="http://pdfs.semanticscholar.org/5314/0a26608c96fd8423705e93f5457aa92aa379.pdf" />
	</analytic>
	<monogr>
		<title level="j">Science</title>
		<idno type="ISSN">0036-8075</idno>
		<idno type="ISSNe">1095-9203</idno>
		<imprint>
			<biblScope unit="volume">287</biblScope>
			<biblScope unit="issue">5457</biblScope>
			<biblScope unit="page" from="1503" to="1506" />
			<date type="published" when="2000-02-25" />
			<publisher>American Association for the Advancement of Science (AAAS)</publisher>
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b32">
	<analytic>
		<title level="a" type="main">Prion-Protein-Specific Aptamer Reduces PrPSc Formation</title>
		<author>
			<persName xmlns="http://www.tei-c.org/ns/1.0"><forename type="first">Daniela</forename><surname>Proske</surname></persName>
		</author>
		<author>
			<persName xmlns="http://www.tei-c.org/ns/1.0"><forename type="first">Sabine</forename><surname>Gilch</surname></persName>
		</author>
		<author>
			<persName xmlns="http://www.tei-c.org/ns/1.0"><forename type="first">Franziska</forename><surname>Wopfner</surname></persName>
		</author>
		<author>
			<persName xmlns="http://www.tei-c.org/ns/1.0"><forename type="first">Hermann</forename><forename type="middle">M</forename><surname>SchÃ¤tzl</surname></persName>
		</author>
		<author>
			<persName xmlns="http://www.tei-c.org/ns/1.0"><forename type="first">Null-</forename><forename type="middle">L</forename><surname>Winnacker</surname></persName>
		</author>
		<author>
			<persName xmlns="http://www.tei-c.org/ns/1.0"><forename type="first">Michael</forename><surname>Famulok</surname></persName>
		</author>
		<idno type="DOI">10.1002/1439-7633(20020802)3:8&lt;717::aid-cbic717&gt;3.0.co;2-c</idno>
		<idno type="PMID">12203970</idno>
		<idno type="ark">ark:/67375/WNG-SK8VCZRM-N</idno>
		<idno type="istexId">424F43205116F61C77E902CBE56765C6BA50B1F7</idno>
	</analytic>
	<monogr>
		<title level="j">ChemBioChem</title>
		<title level="j" type="abbrev">ChemBioChem</title>
		<idno type="ISSN">1439-4227</idno>
		<idno type="ISSNe">1439-7633</idno>
		<imprint>
			<biblScope unit="volume">3</biblScope>
			<biblScope unit="issue">8</biblScope>
			<biblScope unit="page">717</biblScope>
			<date type="published" when="2002-08-02" />
			<publisher>Wiley</publisher>
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b33">
	<monogr>
		<title/>
		<author>
			<persName xmlns="http://www.tei-c.org/ns/1.0"><forename type="first">K</forename><surname>Rezai-Zadeh</surname></persName>
		</author>
		<author>
			<persName xmlns="http://www.tei-c.org/ns/1.0"><forename type="first">D</forename><surname>Shytle</surname></persName>
		</author>
		<author>
			<persName xmlns="http://www.tei-c.org/ns/1.0"><forename type="first">N</forename><surname>Sun</surname></persName>
		</author>
		<author>
			<persName xmlns="http://www.tei-c.org/ns/1.0"><forename type="first">T</forename><surname>Mori</surname></persName>
		</author>
		<author>
			<persName xmlns="http://www.tei-c.org/ns/1.0"><forename type="first">H</forename><surname>Hou</surname></persName>
		</author>
		<author>
			<persName xmlns="http://www.tei-c.org/ns/1.0"><forename type="first">D</forename><surname>Jeanniton</surname></persName>
		</author>
		<author>
			<persName xmlns="http://www.tei-c.org/ns/1.0"><forename type="first">J</forename><surname>Ehrhart</surname></persName>
		</author>
		<author>
			<persName xmlns="http://www.tei-c.org/ns/1.0"><forename type="first">K</forename><surname>Townsend</surname></persName>
		</author>
		<author>
			<persName xmlns="http://www.tei-c.org/ns/1.0"><forename type="first">J</forename><surname>Zeng</surname></persName>
		</author>
		<author>
			<persName xmlns="http://www.tei-c.org/ns/1.0"><forename type="first">Morgan</forename></persName>
		</author>
		<author>
			<persName xmlns="http://www.tei-c.org/ns/1.0"><forename type="first">D</forename></persName>
		</author>
		<imprint>
			<date type="published" when="2005" />
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b34">
	<analytic>
		<title level="a" type="main">Green tea epigallocatechin-3-gallate (EGCG) modulates amyloid precursor protein cleavage and reduces cerebral amyloidosis in Alzheimer transgenic mice</title>
	</analytic>
	<monogr>
		<title level="j">J. Neurosci</title>
		<imprint>
			<biblScope unit="volume">25</biblScope>
			<biblScope unit="page" from="8807" to="8814" />
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b35">
	<analytic>
		<title level="a" type="main">Evaluation of drugs for treatment of prion infections of the central nervous system</title>
		<author>
			<persName xmlns="http://www.tei-c.org/ns/1.0"><forename type="first">C</forename><surname>Riemer</surname></persName>
		</author>
		<author>
			<persName xmlns="http://www.tei-c.org/ns/1.0"><forename type="first">M</forename><surname>Burwinkel</surname></persName>
		</author>
		<author>
			<persName xmlns="http://www.tei-c.org/ns/1.0"><forename type="first">A</forename><surname>Schwarz</surname></persName>
		</author>
		<author>
			<persName xmlns="http://www.tei-c.org/ns/1.0"><forename type="first">S</forename><surname>Gultner</surname></persName>
		</author>
		<author>
			<persName xmlns="http://www.tei-c.org/ns/1.0"><forename type="first">S</forename><forename type="middle">W F</forename><surname>Mok</surname></persName>
		</author>
		<author>
			<persName xmlns="http://www.tei-c.org/ns/1.0"><forename type="first">I</forename><surname>Heise</surname></persName>
		</author>
		<author>
			<persName xmlns="http://www.tei-c.org/ns/1.0"><forename type="first">N</forename><surname>Holtkamp</surname></persName>
		</author>
		<author>
			<persName xmlns="http://www.tei-c.org/ns/1.0"><forename type="first">M</forename><surname>Baier</surname></persName>
		</author>
		<idno type="DOI">10.1099/vir.0.83281-0</idno>
		<idno type="PMID">18198391</idno>
	</analytic>
	<monogr>
		<title level="j">Journal of General Virology</title>
		<title level="j" type="abbrev">Journal of General Virology</title>
		<idno type="ISSN">0022-1317</idno>
		<idno type="ISSNe">1465-2099</idno>
		<imprint>
			<biblScope unit="volume">89</biblScope>
			<biblScope unit="issue">2</biblScope>
			<biblScope unit="page" from="594" to="597" />
			<date type="published" when="2008-02-01" />
			<publisher>Microbiology Society</publisher>
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b36">
	<analytic>
		<title level="a" type="main">Antioxidant and free radical scavenging effects of baicalein, baicalin and wogonin</title>
		<author>
			<persName xmlns="http://www.tei-c.org/ns/1.0"><forename type="first">D</forename><forename type="middle">E</forename><surname>Shieh</surname></persName>
		</author>
		<author>
			<persName xmlns="http://www.tei-c.org/ns/1.0"><forename type="first">L</forename><forename type="middle">T</forename><surname>Liu</surname></persName>
		</author>
		<author>
			<persName xmlns="http://www.tei-c.org/ns/1.0"><forename type="first">C</forename><forename type="middle">C</forename><surname>Lin</surname></persName>
		</author>
	</analytic>
	<monogr>
		<title level="j">Anticancer Res</title>
		<imprint>
			<biblScope unit="volume">20</biblScope>
			<biblScope unit="page" from="2861" to="2865" />
			<date type="published" when="2000" />
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b37">
	<analytic>
		<title level="a" type="main">Protein Misfolding and Neurodegeneration</title>
		<author>
			<persName xmlns="http://www.tei-c.org/ns/1.0"><forename type="first">Claudio</forename><surname>Soto</surname></persName>
		</author>
		<author>
			<persName xmlns="http://www.tei-c.org/ns/1.0"><forename type="first">Lisbell</forename><forename type="middle">D</forename><surname>Estrada</surname></persName>
		</author>
		<idno type="DOI">10.1001/archneurol.2007.56</idno>
		<idno type="PMID">18268186</idno>
		<ptr type="open-access" target="https://jamanetwork.com/journals/jamaneurology/articlepdf/795151/nnr70011_184_189.pdf" />
	</analytic>
	<monogr>
		<title level="j">Archives of Neurology</title>
		<title level="j" type="abbrev">Arch Neurol</title>
		<idno type="ISSN">0003-9942</idno>
		<imprint>
			<biblScope unit="volume">65</biblScope>
			<biblScope unit="issue">2</biblScope>
			<biblScope unit="page" from="184" to="189" />
			<date type="published" when="2008-02-01" />
			<publisher>American Medical Association (AMA)</publisher>
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b38">
	<analytic>
		<title level="a" type="main">Branched Polyamines Cure Prion-Infected Neuroblastoma Cells</title>
		<author>
			<persName xmlns="http://www.tei-c.org/ns/1.0"><forename type="first">S</forename><surname>Supattapone</surname></persName>
		</author>
		<author>
			<persName xmlns="http://www.tei-c.org/ns/1.0"><forename type="first">H</forename><surname>Wille</surname></persName>
		</author>
		<author>
			<persName xmlns="http://www.tei-c.org/ns/1.0"><forename type="first">L</forename><surname>Uyechi</surname></persName>
		</author>
		<author>
			<persName xmlns="http://www.tei-c.org/ns/1.0"><forename type="first">J</forename><surname>Safar</surname></persName>
		</author>
		<author>
			<persName xmlns="http://www.tei-c.org/ns/1.0"><forename type="first">P</forename><surname>Tremblay</surname></persName>
		</author>
		<author>
			<persName xmlns="http://www.tei-c.org/ns/1.0"><forename type="first">F</forename><forename type="middle">C</forename><surname>Szoka</surname></persName>
		</author>
		<author>
			<persName xmlns="http://www.tei-c.org/ns/1.0"><forename type="first">F</forename><forename type="middle">E</forename><surname>Cohen</surname></persName>
		</author>
		<author>
			<persName xmlns="http://www.tei-c.org/ns/1.0"><forename type="first">S</forename><forename type="middle">B</forename><surname>Prusiner</surname></persName>
		</author>
		<author>
			<persName xmlns="http://www.tei-c.org/ns/1.0"><forename type="first">M</forename><forename type="middle">R</forename><surname>Scott</surname></persName>
		</author>
		<idno type="DOI">10.1128/jvi.75.7.3453-3461.2001</idno>
		<idno type="PMID">11238871</idno>
		<idno type="PMCID">PMC114138</idno>
		<ptr type="open-access" target="https://jvi.asm.org/content/75/7/3453.full.pdf" />
	</analytic>
	<monogr>
		<title level="j">Journal of Virology</title>
		<title level="j" type="abbrev">Journal of Virology</title>
		<idno type="ISSN">0022-538X</idno>
		<imprint>
			<biblScope unit="volume">75</biblScope>
			<biblScope unit="issue">7</biblScope>
			<biblScope unit="page" from="3453" to="3461" />
			<date type="published" when="2001-04-01" />
			<publisher>American Society for Microbiology</publisher>
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b39">
	<analytic>
		<title level="a" type="main">Baicalin, a prodrug able to reach the CNS, is a prolyl oligopeptidase inhibitor</title>
		<author>
			<persName xmlns="http://www.tei-c.org/ns/1.0"><forename type="first">Teresa</forename><surname>TarragÃ³</surname></persName>
		</author>
		<author>
			<persName xmlns="http://www.tei-c.org/ns/1.0"><forename type="first">Nessim</forename><surname>Kichik</surname></persName>
		</author>
		<author>
			<persName xmlns="http://www.tei-c.org/ns/1.0"><forename type="first">Birgit</forename><surname>Claasen</surname></persName>
		</author>
		<author>
			<persName xmlns="http://www.tei-c.org/ns/1.0"><forename type="first">Roger</forename><surname>Prades</surname></persName>
		</author>
		<author>
			<persName xmlns="http://www.tei-c.org/ns/1.0"><forename type="first">Meritxell</forename><surname>TeixidÃ³</surname></persName>
		</author>
		<author>
			<persName xmlns="http://www.tei-c.org/ns/1.0"><forename type="first">Ernest</forename><surname>Giralt</surname></persName>
		</author>
		<idno type="DOI">10.1016/j.bmc.2008.04.067</idno>
		<idno type="PMID">18650094</idno>
	</analytic>
	<monogr>
		<title level="j">Bioorganic &amp; Medicinal Chemistry</title>
		<title level="j" type="abbrev">Bioorganic &amp; Medicinal Chemistry</title>
		<idno type="ISSN">0968-0896</idno>
		<imprint>
			<biblScope unit="volume">16</biblScope>
			<biblScope unit="issue">15</biblScope>
			<biblScope unit="page" from="7516" to="7524" />
			<date type="published" when="2008-08" />
			<publisher>Elsevier BV</publisher>
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b40">
	<analytic>
		<title level="a" type="main">The effects of the cyclosporin A, a P-glycoprotein inhibitor, on the pharmacokinetics of baicalein in the rat: a microdialysis study</title>
		<author>
			<persName xmlns="http://www.tei-c.org/ns/1.0"><forename type="first">T</forename><forename type="middle">H</forename><surname>Tsai</surname></persName>
		</author>
		<author>
			<persName xmlns="http://www.tei-c.org/ns/1.0"><forename type="first">S</forename><forename type="middle">C</forename><surname>Liu</surname></persName>
		</author>
		<author>
			<persName xmlns="http://www.tei-c.org/ns/1.0"><forename type="first">P</forename><forename type="middle">L</forename><surname>Tsai</surname></persName>
		</author>
		<author>
			<persName xmlns="http://www.tei-c.org/ns/1.0"><forename type="first">L</forename><forename type="middle">K</forename><surname>Ho</surname></persName>
		</author>
		<author>
			<persName xmlns="http://www.tei-c.org/ns/1.0"><forename type="first">A</forename><forename type="middle">Y C</forename><surname>Shum</surname></persName>
		</author>
		<author>
			<persName xmlns="http://www.tei-c.org/ns/1.0"><forename type="first">C</forename><forename type="middle">F</forename><surname>Chen</surname></persName>
		</author>
		<idno type="DOI">10.1038/sj.bjp.0704959</idno>
		<idno type="PMID">12466241</idno>
		<idno type="PMCID">PMC1573598</idno>
		<ptr type="open-access" target="http://europepmc.org/articles/pmc1573598?pdf=render" />
	</analytic>
	<monogr>
		<title level="j">British Journal of Pharmacology</title>
		<idno type="ISSN">0007-1188</idno>
		<idno type="ISSNe">1476-5381</idno>
		<imprint>
			<biblScope unit="volume">137</biblScope>
			<biblScope unit="issue">8</biblScope>
			<biblScope unit="page" from="1314" to="1320" />
			<date type="published" when="2002-12" />
			<publisher>Wiley</publisher>
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b41">
	<analytic>
		<title level="a" type="main">Oral pravastatin prolongs survival time of scrapie-infected mice</title>
		<author>
			<persName xmlns="http://www.tei-c.org/ns/1.0"><forename type="first">V</forename><surname>Vetrugno</surname></persName>
		</author>
		<author>
			<persName xmlns="http://www.tei-c.org/ns/1.0"><forename type="first">M</forename><forename type="middle">A</forename><surname>Di Bari</surname></persName>
		</author>
		<author>
			<persName xmlns="http://www.tei-c.org/ns/1.0"><forename type="first">R</forename><surname>Nonno</surname></persName>
		</author>
		<author>
			<persName xmlns="http://www.tei-c.org/ns/1.0"><forename type="first">M</forename><surname>Puopolo</surname></persName>
		</author>
		<author>
			<persName xmlns="http://www.tei-c.org/ns/1.0"><forename type="first">C</forename><surname>D'agostino</surname></persName>
		</author>
		<author>
			<persName xmlns="http://www.tei-c.org/ns/1.0"><forename type="first">L</forename><surname>Pirisinu</surname></persName>
		</author>
		<author>
			<persName xmlns="http://www.tei-c.org/ns/1.0"><forename type="first">M</forename><surname>Pocchiari</surname></persName>
		</author>
		<author>
			<persName xmlns="http://www.tei-c.org/ns/1.0"><forename type="first">U</forename><surname>Agrimi</surname></persName>
		</author>
		<idno type="DOI">10.1099/vir.0.009936-0</idno>
		<idno type="PMID">19282428</idno>
	</analytic>
	<monogr>
		<title level="j">Journal of General Virology</title>
		<title level="j" type="abbrev">Journal of General Virology</title>
		<idno type="ISSN">0022-1317</idno>
		<idno type="ISSNe">1465-2099</idno>
		<imprint>
			<biblScope unit="volume">90</biblScope>
			<biblScope unit="issue">7</biblScope>
			<biblScope unit="page" from="1775" to="1780" />
			<date type="published" when="2009-03-12" />
			<publisher>Microbiology Society</publisher>
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b42">
	<analytic>
		<title level="a" type="main">Consumption of Grape Seed Extract Prevents Amyloid-Î² Deposition and Attenuates Inflammation in Brain of an Alzheimerâs Disease Mouse</title>
		<author>
			<persName xmlns="http://www.tei-c.org/ns/1.0"><forename type="first">Yan-Jiang</forename><surname>Wang</surname></persName>
		</author>
		<author>
			<persName xmlns="http://www.tei-c.org/ns/1.0"><forename type="first">Philip</forename><surname>Thomas</surname></persName>
		</author>
		<author>
			<persName xmlns="http://www.tei-c.org/ns/1.0"><forename type="first">Jin-Hua</forename><surname>Zhong</surname></persName>
		</author>
		<author>
			<persName xmlns="http://www.tei-c.org/ns/1.0"><forename type="first">Fang-Fang</forename><surname>Bi</surname></persName>
		</author>
		<author>
			<persName xmlns="http://www.tei-c.org/ns/1.0"><forename type="first">Shantha</forename><surname>Kosaraju</surname></persName>
		</author>
		<author>
			<persName xmlns="http://www.tei-c.org/ns/1.0"><forename type="first">Anthony</forename><surname>Pollard</surname></persName>
		</author>
		<author>
			<persName xmlns="http://www.tei-c.org/ns/1.0"><forename type="first">Michael</forename><surname>Fenech</surname></persName>
		</author>
		<author>
			<persName xmlns="http://www.tei-c.org/ns/1.0"><forename type="first">Xin-Fu</forename><surname>Zhou</surname></persName>
		</author>
		<idno type="DOI">10.1007/s12640-009-9000-x</idno>
		<idno type="PMID">19384583</idno>
	</analytic>
	<monogr>
		<title level="j">Neurotoxicity Research</title>
		<title level="j" type="abbrev">Neurotox Res</title>
		<idno type="ISSN">1029-8428</idno>
		<idno type="ISSNe">1476-3524</idno>
		<imprint>
			<biblScope unit="volume">15</biblScope>
			<biblScope unit="issue">1</biblScope>
			<biblScope unit="page" from="3" to="14" />
			<date type="published" when="2009-01" />
			<publisher>Springer Nature</publisher>
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b43">
	<analytic>
		<title level="a" type="main">Monoclonal antibodies inhibit prion replication and delay the development of prion disease</title>
		<author>
			<persName xmlns="http://www.tei-c.org/ns/1.0"><forename type="first">Anthony</forename><forename type="middle">R</forename><surname>White</surname></persName>
		</author>
		<author>
			<persName xmlns="http://www.tei-c.org/ns/1.0"><forename type="first">Perry</forename><surname>Enever</surname></persName>
		</author>
		<author>
			<persName xmlns="http://www.tei-c.org/ns/1.0"><forename type="first">Mourad</forename><surname>Tayebi</surname></persName>
		</author>
		<author>
			<persName xmlns="http://www.tei-c.org/ns/1.0"><forename type="first">Rosey</forename><surname>Mushens</surname></persName>
		</author>
		<author>
			<persName xmlns="http://www.tei-c.org/ns/1.0"><forename type="first">Jackie</forename><surname>Linehan</surname></persName>
		</author>
		<author>
			<persName xmlns="http://www.tei-c.org/ns/1.0"><forename type="first">Sebastian</forename><surname>Brandner</surname></persName>
		</author>
		<author>
			<persName xmlns="http://www.tei-c.org/ns/1.0"><forename type="first">David</forename><surname>Anstee</surname></persName>
		</author>
		<author>
			<persName xmlns="http://www.tei-c.org/ns/1.0"><forename type="first">John</forename><surname>Collinge</surname></persName>
		</author>
		<author>
			<persName xmlns="http://www.tei-c.org/ns/1.0"><forename type="first">Simon</forename><surname>Hawke</surname></persName>
		</author>
		<idno type="DOI">10.1038/nature01457</idno>
		<idno type="PMID">12621436</idno>
		<idno type="ark">ark:/67375/GT4-N39DV56B-G</idno>
		<idno type="istexId">F2E15498F5DF7F8FBAC8F224590CB9B2CDB9CA10</idno>
	</analytic>
	<monogr>
		<title level="j">Nature</title>
		<title level="j" type="abbrev">Nature</title>
		<idno type="ISSN">0028-0836</idno>
		<idno type="ISSNe">1476-4687</idno>
		<imprint>
			<biblScope unit="volume">422</biblScope>
			<biblScope unit="issue">6927</biblScope>
			<biblScope unit="page" from="80" to="83" />
			<date type="published" when="2003-03" />
			<publisher>Springer Nature</publisher>
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b44">
	<analytic>
		<title level="a" type="main">Curcumin Inhibits Formation of Amyloid Î² Oligomers and Fibrils, Binds Plaques, and Reduces Amyloidin Vivo</title>
		<author>
			<persName xmlns="http://www.tei-c.org/ns/1.0"><forename type="first">Fusheng</forename><surname>Yang</surname></persName>
		</author>
		<author>
			<persName xmlns="http://www.tei-c.org/ns/1.0"><forename type="first">Giselle</forename><forename type="middle">P</forename><surname>Lim</surname></persName>
		</author>
		<author>
			<persName xmlns="http://www.tei-c.org/ns/1.0"><forename type="first">Aynun</forename><forename type="middle">N</forename><surname>Begum</surname></persName>
		</author>
		<author>
			<persName xmlns="http://www.tei-c.org/ns/1.0"><forename type="first">Oliver</forename><forename type="middle">J</forename><surname>Ubeda</surname></persName>
		</author>
		<author>
			<persName xmlns="http://www.tei-c.org/ns/1.0"><forename type="first">Mychica</forename><forename type="middle">R</forename><surname>Simmons</surname></persName>
		</author>
		<author>
			<persName xmlns="http://www.tei-c.org/ns/1.0"><forename type="first">Surendra</forename><forename type="middle">S</forename><surname>Ambegaokar</surname></persName>
		</author>
		<author>
			<persName xmlns="http://www.tei-c.org/ns/1.0"><forename type="first">Pingping</forename><forename type="middle">P</forename><surname>Chen</surname></persName>
		</author>
		<author>
			<persName xmlns="http://www.tei-c.org/ns/1.0"><forename type="first">Rakez</forename><surname>Kayed</surname></persName>
		</author>
		<author>
			<persName xmlns="http://www.tei-c.org/ns/1.0"><forename type="first">Charles</forename><forename type="middle">G</forename><surname>Glabe</surname></persName>
		</author>
		<author>
			<persName xmlns="http://www.tei-c.org/ns/1.0"><forename type="first">Sally</forename><forename type="middle">A</forename><surname>Frautschy</surname></persName>
		</author>
		<author>
			<persName xmlns="http://www.tei-c.org/ns/1.0"><forename type="first">Gregory</forename><forename type="middle">M</forename><surname>Cole</surname></persName>
		</author>
		<idno type="DOI">10.1074/jbc.m404751200</idno>
		<idno type="PMID">15590663</idno>
		<ptr type="open-access" target="http://www.jbc.org/content/280/7/5892.full.pdf" />
	</analytic>
	<monogr>
		<title level="j">Journal of Biological Chemistry</title>
		<title level="j" type="abbrev">J. Biol. Chem.</title>
		<idno type="ISSN">0021-9258</idno>
		<idno type="ISSNe">1083-351X</idno>
		<imprint>
			<biblScope unit="volume">280</biblScope>
			<biblScope unit="issue">7</biblScope>
			<biblScope unit="page" from="5892" to="5901" />
			<date type="published" when="2004-12-07" />
			<publisher>American Society for Biochemistry &amp; Molecular Biology (ASBMB)</publisher>
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b45">
	<analytic>
		<title level="a" type="main">The Flavonoid Baicalein Inhibits Fibrillation of Î±-Synuclein and Disaggregates Existing Fibrils</title>
		<author>
			<persName xmlns="http://www.tei-c.org/ns/1.0"><forename type="first">Min</forename><surname>Zhu</surname></persName>
		</author>
		<author>
			<persName xmlns="http://www.tei-c.org/ns/1.0"><forename type="first">Sudha</forename><surname>Rajamani</surname></persName>
		</author>
		<author>
			<persName xmlns="http://www.tei-c.org/ns/1.0"><forename type="first">Joanna</forename><surname>Kaylor</surname></persName>
		</author>
		<author>
			<persName xmlns="http://www.tei-c.org/ns/1.0"><forename type="first">Shubo</forename><surname>Han</surname></persName>
		</author>
		<author>
			<persName xmlns="http://www.tei-c.org/ns/1.0"><forename type="first">Feimeng</forename><surname>Zhou</surname></persName>
		</author>
		<author>
			<persName xmlns="http://www.tei-c.org/ns/1.0"><forename type="first">Anthony</forename><forename type="middle">L</forename><surname>Fink</surname></persName>
		</author>
		<idno type="DOI">10.1074/jbc.m403129200</idno>
		<idno type="PMID">15096521</idno>
		<ptr type="open-access" target="http://www.jbc.org/content/279/26/26846.full.pdf" />
	</analytic>
	<monogr>
		<title level="j">Journal of Biological Chemistry</title>
		<title level="j" type="abbrev">J. Biol. Chem.</title>
		<idno type="ISSN">0021-9258</idno>
		<idno type="ISSNe">1083-351X</idno>
		<imprint>
			<biblScope unit="volume">279</biblScope>
			<biblScope unit="issue">26</biblScope>
			<biblScope unit="page" from="26846" to="26857" />
			<date type="published" when="2004-04-19" />
			<publisher>American Society for Biochemistry &amp; Molecular Biology (ASBMB)</publisher>
		</imprint>
	</monogr>
</biblStruct>

				</listBibl>
			</div>
		</back>
	</text>
</TEI>
